JP3138452B2 - Genes involved in anther dehiscence - Google Patents
Genes involved in anther dehiscenceInfo
- Publication number
- JP3138452B2 JP3138452B2 JP11115002A JP11500299A JP3138452B2 JP 3138452 B2 JP3138452 B2 JP 3138452B2 JP 11115002 A JP11115002 A JP 11115002A JP 11500299 A JP11500299 A JP 11500299A JP 3138452 B2 JP3138452 B2 JP 3138452B2
- Authority
- JP
- Japan
- Prior art keywords
- dna
- leu
- ser
- gene
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 60
- 230000004814 anther dehiscence Effects 0.000 title claims description 16
- 238000000034 method Methods 0.000 claims description 57
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 claims description 27
- 230000014509 gene expression Effects 0.000 claims description 18
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- ZNJFBWYDHIGLCU-UHFFFAOYSA-N jasmonic acid Natural products CCC=CCC1C(CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-UHFFFAOYSA-N 0.000 claims description 13
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 11
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 11
- 229960004488 linolenic acid Drugs 0.000 claims description 11
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims description 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 230000035558 fertility Effects 0.000 claims description 9
- 230000035772 mutation Effects 0.000 claims description 5
- 230000000694 effects Effects 0.000 claims description 4
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 108020004414 DNA Proteins 0.000 description 75
- 241000196324 Embryophyta Species 0.000 description 65
- 101150037150 DAD1 gene Proteins 0.000 description 40
- 239000013598 vector Substances 0.000 description 23
- 241000219195 Arabidopsis thaliana Species 0.000 description 18
- 239000013612 plasmid Substances 0.000 description 17
- 239000012634 fragment Substances 0.000 description 14
- 230000000692 anti-sense effect Effects 0.000 description 11
- 206010021929 Infertility male Diseases 0.000 description 10
- 208000007466 Male Infertility Diseases 0.000 description 10
- 238000012546 transfer Methods 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 7
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 239000002299 complementary DNA Substances 0.000 description 7
- 241000282326 Felis catus Species 0.000 description 6
- 239000003471 mutagenic agent Substances 0.000 description 6
- 231100000707 mutagenic chemical Toxicity 0.000 description 6
- 230000003505 mutagenic effect Effects 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 5
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 description 4
- 241000219194 Arabidopsis Species 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000003776 cleavage reaction Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000007017 scission Effects 0.000 description 4
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 3
- 241000219193 Brassicaceae Species 0.000 description 3
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 108010089804 glycyl-threonine Proteins 0.000 description 3
- 108010025306 histidylleucine Proteins 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000010899 nucleation Methods 0.000 description 3
- 239000013600 plasmid vector Substances 0.000 description 3
- 108010026333 seryl-proline Proteins 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- QKHWNPQNOHEFST-VZFHVOOUSA-N Ala-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N)O QKHWNPQNOHEFST-VZFHVOOUSA-N 0.000 description 2
- IOFVWPYSRSCWHI-JXUBOQSCSA-N Ala-Thr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)N IOFVWPYSRSCWHI-JXUBOQSCSA-N 0.000 description 2
- BOKLLPVAQDSLHC-FXQIFTODSA-N Ala-Val-Cys Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)O)N BOKLLPVAQDSLHC-FXQIFTODSA-N 0.000 description 2
- NLRJGXZWTKXRHP-DCAQKATOSA-N Asn-Leu-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NLRJGXZWTKXRHP-DCAQKATOSA-N 0.000 description 2
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 2
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- KZEUVLLVULIPNX-GUBZILKMSA-N Gln-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N KZEUVLLVULIPNX-GUBZILKMSA-N 0.000 description 2
- UPOJUWHGMDJUQZ-IUCAKERBSA-N Gly-Arg-Arg Chemical compound NC(=N)NCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UPOJUWHGMDJUQZ-IUCAKERBSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- ZDNNDIJTUHQCAM-MXAVVETBSA-N Ile-Ser-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N ZDNNDIJTUHQCAM-MXAVVETBSA-N 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 235000003228 Lactuca sativa Nutrition 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 2
- YRRCOJOXAJNSAX-IHRRRGAJSA-N Leu-Pro-Lys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N YRRCOJOXAJNSAX-IHRRRGAJSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- BRTVHXHCUSXYRI-CIUDSAMLSA-N Leu-Ser-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O BRTVHXHCUSXYRI-CIUDSAMLSA-N 0.000 description 2
- OBVHKUFUDCPZDW-JYJNAYRXSA-N Met-Arg-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OBVHKUFUDCPZDW-JYJNAYRXSA-N 0.000 description 2
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- AQSMZTIEJMZQEC-DCAQKATOSA-N Pro-His-Ser Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CO)C(=O)O AQSMZTIEJMZQEC-DCAQKATOSA-N 0.000 description 2
- XSXABUHLKPUVLX-JYJNAYRXSA-N Pro-Ser-Trp Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O XSXABUHLKPUVLX-JYJNAYRXSA-N 0.000 description 2
- WWXNZNWZNZPDIF-SRVKXCTJSA-N Pro-Val-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 WWXNZNWZNZPDIF-SRVKXCTJSA-N 0.000 description 2
- 108700008625 Reporter Genes Proteins 0.000 description 2
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 2
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 2
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 2
- FHXGMDRKJHKLKW-QWRGUYRKSA-N Ser-Tyr-Gly Chemical compound OC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 FHXGMDRKJHKLKW-QWRGUYRKSA-N 0.000 description 2
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 2
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 2
- XTDDIVQWDXMRJL-IHRRRGAJSA-N Val-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N XTDDIVQWDXMRJL-IHRRRGAJSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 2
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 2
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 2
- 108010027371 asparaginyl-leucyl-prolyl-arginine Proteins 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010363 gene targeting Methods 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 108010018006 histidylserine Proteins 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 2
- 108010051242 phenylalanylserine Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- UNZSHUCNBUBSGW-IFNWOZJISA-M sodium;(9z,12z,15z)-octadeca-9,12,15-trienoate Chemical compound [Na+].CC\C=C/C\C=C/C\C=C/CCCCCCCC([O-])=O UNZSHUCNBUBSGW-IFNWOZJISA-M 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- 229910052902 vermiculite Inorganic materials 0.000 description 2
- 235000019354 vermiculite Nutrition 0.000 description 2
- 239000010455 vermiculite Substances 0.000 description 2
- NTUPOKHATNSWCY-PMPSAXMXSA-N (2s)-2-[[(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=CC=C1 NTUPOKHATNSWCY-PMPSAXMXSA-N 0.000 description 1
- IKWHIGGRTYBSIW-OBJOEFQTSA-N (2s)-2-[[(2s)-2-[[(2s)-1-(2-aminoacetyl)pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoic acid Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN IKWHIGGRTYBSIW-OBJOEFQTSA-N 0.000 description 1
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- LGGQQYXFFSOIJY-UHFFFAOYSA-N 2-(3-methylbut-2-enyl)-7h-purin-6-amine Chemical compound CC(C)=CCC1=NC(N)=C2NC=NC2=N1 LGGQQYXFFSOIJY-UHFFFAOYSA-N 0.000 description 1
- YEJQWBFDKKTPNO-UHFFFAOYSA-N 2-[[2-[[1-(2-amino-3-methylbutanoyl)pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-methylbutanoic acid Chemical compound CC(C)C(N)C(=O)N1CCCC1C(=O)NCC(=O)NC(C(C)C)C(O)=O YEJQWBFDKKTPNO-UHFFFAOYSA-N 0.000 description 1
- JXCKZXHCJOVIAV-UHFFFAOYSA-N 6-[(5-bromo-4-chloro-1h-indol-3-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid;cyclohexanamine Chemical compound [NH3+]C1CCCCC1.O1C(C([O-])=O)C(O)C(O)C(O)C1OC1=CNC2=CC=C(Br)C(Cl)=C12 JXCKZXHCJOVIAV-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- LGQPPBQRUBVTIF-JBDRJPRFSA-N Ala-Ala-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LGQPPBQRUBVTIF-JBDRJPRFSA-N 0.000 description 1
- NXSFUECZFORGOG-CIUDSAMLSA-N Ala-Asn-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXSFUECZFORGOG-CIUDSAMLSA-N 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- JAQNUEWEJWBVAY-WBAXXEDZSA-N Ala-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 JAQNUEWEJWBVAY-WBAXXEDZSA-N 0.000 description 1
- BHTBAVZSZCQZPT-GUBZILKMSA-N Ala-Pro-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)N BHTBAVZSZCQZPT-GUBZILKMSA-N 0.000 description 1
- HCBKAOZYACJUEF-XQXXSGGOSA-N Ala-Thr-Gln Chemical compound N[C@@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCC(N)=O)C(=O)O HCBKAOZYACJUEF-XQXXSGGOSA-N 0.000 description 1
- YCTIYBUTCKNOTI-UWJYBYFXSA-N Ala-Tyr-Asp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCTIYBUTCKNOTI-UWJYBYFXSA-N 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- DBKNLHKEVPZVQC-LPEHRKFASA-N Arg-Ala-Pro Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(O)=O DBKNLHKEVPZVQC-LPEHRKFASA-N 0.000 description 1
- BIOCIVSVEDFKDJ-GUBZILKMSA-N Arg-Arg-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O BIOCIVSVEDFKDJ-GUBZILKMSA-N 0.000 description 1
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 1
- JTKLCCFLSLCCST-SZMVWBNQSA-N Arg-Arg-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N)C(O)=O)=CNC2=C1 JTKLCCFLSLCCST-SZMVWBNQSA-N 0.000 description 1
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 1
- RWDVGVPHEWOZMO-GUBZILKMSA-N Arg-Cys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCCNC(N)=N)C(O)=O RWDVGVPHEWOZMO-GUBZILKMSA-N 0.000 description 1
- BGDILZXXDJCKPF-CIUDSAMLSA-N Arg-Gln-Cys Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O BGDILZXXDJCKPF-CIUDSAMLSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- KRQSPVKUISQQFS-FJXKBIBVSA-N Arg-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N KRQSPVKUISQQFS-FJXKBIBVSA-N 0.000 description 1
- LLUGJARLJCGLAR-CYDGBPFRSA-N Arg-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N LLUGJARLJCGLAR-CYDGBPFRSA-N 0.000 description 1
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 1
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 1
- POZKLUIXMHIULG-FDARSICLSA-N Arg-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCCN=C(N)N)N POZKLUIXMHIULG-FDARSICLSA-N 0.000 description 1
- VLIJAPRTSXSGFY-STQMWFEESA-N Arg-Tyr-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 VLIJAPRTSXSGFY-STQMWFEESA-N 0.000 description 1
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- YJRORCOAFUZVKA-FXQIFTODSA-N Asn-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N YJRORCOAFUZVKA-FXQIFTODSA-N 0.000 description 1
- CIBWFJFMOBIFTE-CIUDSAMLSA-N Asn-Arg-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N)CN=C(N)N CIBWFJFMOBIFTE-CIUDSAMLSA-N 0.000 description 1
- BDMIFVIWCNLDCT-CIUDSAMLSA-N Asn-Arg-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O BDMIFVIWCNLDCT-CIUDSAMLSA-N 0.000 description 1
- FTCGGKNCJZOPNB-WHFBIAKZSA-N Asn-Gly-Ser Chemical compound NC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FTCGGKNCJZOPNB-WHFBIAKZSA-N 0.000 description 1
- ZMUQQMGITUJQTI-CIUDSAMLSA-N Asn-Leu-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O ZMUQQMGITUJQTI-CIUDSAMLSA-N 0.000 description 1
- VWADICJNCPFKJS-ZLUOBGJFSA-N Asn-Ser-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O VWADICJNCPFKJS-ZLUOBGJFSA-N 0.000 description 1
- BIGRHVNFFJTHEB-UBHSHLNASA-N Asn-Trp-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O BIGRHVNFFJTHEB-UBHSHLNASA-N 0.000 description 1
- CBWCQCANJSGUOH-ZKWXMUAHSA-N Asn-Val-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O CBWCQCANJSGUOH-ZKWXMUAHSA-N 0.000 description 1
- LMIWYCWRJVMAIQ-NHCYSSNCSA-N Asn-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N LMIWYCWRJVMAIQ-NHCYSSNCSA-N 0.000 description 1
- QOVWVLLHMMCFFY-ZLUOBGJFSA-N Asp-Asp-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QOVWVLLHMMCFFY-ZLUOBGJFSA-N 0.000 description 1
- PXLNPFOJZQMXAT-BYULHYEWSA-N Asp-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O PXLNPFOJZQMXAT-BYULHYEWSA-N 0.000 description 1
- PMEHKVHZQKJACS-PEFMBERDSA-N Asp-Gln-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PMEHKVHZQKJACS-PEFMBERDSA-N 0.000 description 1
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 1
- DJCAHYVLMSRBFR-QXEWZRGKSA-N Asp-Met-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O DJCAHYVLMSRBFR-QXEWZRGKSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- YFGUZQQCSDZRBN-DCAQKATOSA-N Asp-Pro-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O YFGUZQQCSDZRBN-DCAQKATOSA-N 0.000 description 1
- FOXXZZGDIAQPQI-XKNYDFJKSA-N Asp-Pro-Ser-Ser Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O FOXXZZGDIAQPQI-XKNYDFJKSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- FMGBNISRFNDECK-CZSBRECXSA-N Coronatine Chemical compound CC[C@H]1C[C@]1(C(O)=O)NC(=O)C1=C[C@H](CC)C[C@@H]2C(=O)CC[C@H]12 FMGBNISRFNDECK-CZSBRECXSA-N 0.000 description 1
- OCEHKDFAWQIBHH-FXQIFTODSA-N Cys-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N OCEHKDFAWQIBHH-FXQIFTODSA-N 0.000 description 1
- KPENUVBHAKRDQR-GUBZILKMSA-N Cys-His-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPENUVBHAKRDQR-GUBZILKMSA-N 0.000 description 1
- XLLSMEFANRROJE-GUBZILKMSA-N Cys-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N XLLSMEFANRROJE-GUBZILKMSA-N 0.000 description 1
- UDDITVWSXPEAIQ-IHRRRGAJSA-N Cys-Phe-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UDDITVWSXPEAIQ-IHRRRGAJSA-N 0.000 description 1
- 102000004594 DNA Polymerase I Human genes 0.000 description 1
- 108010017826 DNA Polymerase I Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101100478633 Escherichia coli O157:H7 stcE gene Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- DXMPMSWUZVNBSG-QEJZJMRPSA-N Gln-Asn-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N DXMPMSWUZVNBSG-QEJZJMRPSA-N 0.000 description 1
- QYTKAVBFRUGYAU-ACZMJKKPSA-N Gln-Asp-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QYTKAVBFRUGYAU-ACZMJKKPSA-N 0.000 description 1
- IXFVOPOHSRKJNG-LAEOZQHASA-N Gln-Asp-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IXFVOPOHSRKJNG-LAEOZQHASA-N 0.000 description 1
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 1
- QFXNFFZTMFHPST-DZKIICNBSA-N Gln-Phe-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)N)N QFXNFFZTMFHPST-DZKIICNBSA-N 0.000 description 1
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 1
- WOSRKEJQESVHGA-CIUDSAMLSA-N Glu-Arg-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O WOSRKEJQESVHGA-CIUDSAMLSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- ZWABFSSWTSAMQN-KBIXCLLPSA-N Glu-Ile-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O ZWABFSSWTSAMQN-KBIXCLLPSA-N 0.000 description 1
- ITBHUUMCJJQUSC-LAEOZQHASA-N Glu-Ile-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O ITBHUUMCJJQUSC-LAEOZQHASA-N 0.000 description 1
- QXDXIXFSFHUYAX-MNXVOIDGSA-N Glu-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O QXDXIXFSFHUYAX-MNXVOIDGSA-N 0.000 description 1
- OQXDUSZKISQQSS-GUBZILKMSA-N Glu-Lys-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OQXDUSZKISQQSS-GUBZILKMSA-N 0.000 description 1
- UJMNFCAHLYKWOZ-DCAQKATOSA-N Glu-Lys-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O UJMNFCAHLYKWOZ-DCAQKATOSA-N 0.000 description 1
- FGSGPLRPQCZBSQ-AVGNSLFASA-N Glu-Phe-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O FGSGPLRPQCZBSQ-AVGNSLFASA-N 0.000 description 1
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- HZISRJBYZAODRV-XQXXSGGOSA-N Glu-Thr-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O HZISRJBYZAODRV-XQXXSGGOSA-N 0.000 description 1
- UMZHHILWZBFPGL-LOKLDPHHSA-N Glu-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O UMZHHILWZBFPGL-LOKLDPHHSA-N 0.000 description 1
- QVXWAFZDWRLXTI-NWLDYVSISA-N Glu-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O QVXWAFZDWRLXTI-NWLDYVSISA-N 0.000 description 1
- DWUKOTKSTDWGAE-BQBZGAKWSA-N Gly-Asn-Arg Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DWUKOTKSTDWGAE-BQBZGAKWSA-N 0.000 description 1
- BUEFQXUHTUZXHR-LURJTMIESA-N Gly-Gly-Pro zwitterion Chemical compound NCC(=O)NCC(=O)N1CCC[C@H]1C(O)=O BUEFQXUHTUZXHR-LURJTMIESA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- TWTPDFFBLQEBOE-IUCAKERBSA-N Gly-Leu-Gln Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O TWTPDFFBLQEBOE-IUCAKERBSA-N 0.000 description 1
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- GMTXWRIDLGTVFC-IUCAKERBSA-N Gly-Lys-Glu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMTXWRIDLGTVFC-IUCAKERBSA-N 0.000 description 1
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 1
- GLACUWHUYFBSPJ-FJXKBIBVSA-N Gly-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN GLACUWHUYFBSPJ-FJXKBIBVSA-N 0.000 description 1
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- ZKJZBRHRWKLVSJ-ZDLURKLDSA-N Gly-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN)O ZKJZBRHRWKLVSJ-ZDLURKLDSA-N 0.000 description 1
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 1
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 1
- GWNIGUKSRJBIHX-STQMWFEESA-N Gly-Tyr-Arg Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)CN)O GWNIGUKSRJBIHX-STQMWFEESA-N 0.000 description 1
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 1
- FULZDMOZUZKGQU-ONGXEEELSA-N Gly-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN FULZDMOZUZKGQU-ONGXEEELSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- AAXMRLWFJFDYQO-GUBZILKMSA-N His-Asp-Gln Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O AAXMRLWFJFDYQO-GUBZILKMSA-N 0.000 description 1
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- QIHJTGSVGIPHIW-QSFUFRPTSA-N Ile-Asn-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N QIHJTGSVGIPHIW-QSFUFRPTSA-N 0.000 description 1
- BSWLQVGEVFYGIM-ZPFDUUQYSA-N Ile-Gln-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N BSWLQVGEVFYGIM-ZPFDUUQYSA-N 0.000 description 1
- PKGGWLOLRLOPGK-XUXIUFHCSA-N Ile-Leu-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PKGGWLOLRLOPGK-XUXIUFHCSA-N 0.000 description 1
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 1
- FTUZWJVSNZMLPI-RVMXOQNASA-N Ile-Met-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N FTUZWJVSNZMLPI-RVMXOQNASA-N 0.000 description 1
- KCTIFOCXAIUQQK-QXEWZRGKSA-N Ile-Pro-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O KCTIFOCXAIUQQK-QXEWZRGKSA-N 0.000 description 1
- MLSUZXHSNRBDCI-CYDGBPFRSA-N Ile-Pro-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)O)N MLSUZXHSNRBDCI-CYDGBPFRSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- QGXQHJQPAPMACW-PPCPHDFISA-N Ile-Thr-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)O)N QGXQHJQPAPMACW-PPCPHDFISA-N 0.000 description 1
- ZYVTXBXHIKGZMD-QSFUFRPTSA-N Ile-Val-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZYVTXBXHIKGZMD-QSFUFRPTSA-N 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- REPPKAMYTOJTFC-DCAQKATOSA-N Leu-Arg-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O REPPKAMYTOJTFC-DCAQKATOSA-N 0.000 description 1
- VIWUBXKCYJGNCL-SRVKXCTJSA-N Leu-Asn-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 VIWUBXKCYJGNCL-SRVKXCTJSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- MMEDVBWCMGRKKC-GARJFASQSA-N Leu-Asp-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N MMEDVBWCMGRKKC-GARJFASQSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 1
- HQUXQAMSWFIRET-AVGNSLFASA-N Leu-Glu-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN HQUXQAMSWFIRET-AVGNSLFASA-N 0.000 description 1
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- CSFVADKICPDRRF-KKUMJFAQSA-N Leu-His-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CN=CN1 CSFVADKICPDRRF-KKUMJFAQSA-N 0.000 description 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 1
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 1
- RRVCZCNFXIFGRA-DCAQKATOSA-N Leu-Pro-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O RRVCZCNFXIFGRA-DCAQKATOSA-N 0.000 description 1
- CHJKEDSZNSONPS-DCAQKATOSA-N Leu-Pro-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O CHJKEDSZNSONPS-DCAQKATOSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- SVBJIZVVYJYGLA-DCAQKATOSA-N Leu-Ser-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O SVBJIZVVYJYGLA-DCAQKATOSA-N 0.000 description 1
- FGZVGOAAROXFAB-IXOXFDKPSA-N Leu-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N)O FGZVGOAAROXFAB-IXOXFDKPSA-N 0.000 description 1
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 1
- FACUGMGEFUEBTI-SRVKXCTJSA-N Lys-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCCN FACUGMGEFUEBTI-SRVKXCTJSA-N 0.000 description 1
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 1
- YFQSSOAGMZGXFT-MEYUZBJRSA-N Lys-Thr-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YFQSSOAGMZGXFT-MEYUZBJRSA-N 0.000 description 1
- DRRXXZBXDMLGFC-IHRRRGAJSA-N Lys-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN DRRXXZBXDMLGFC-IHRRRGAJSA-N 0.000 description 1
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 1
- HUKLXYYPZWPXCC-KZVJFYERSA-N Met-Ala-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O HUKLXYYPZWPXCC-KZVJFYERSA-N 0.000 description 1
- STTRPDDKDVKIDF-KKUMJFAQSA-N Met-Glu-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 STTRPDDKDVKIDF-KKUMJFAQSA-N 0.000 description 1
- GMMLGMFBYCFCCX-KZVJFYERSA-N Met-Thr-Ala Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O GMMLGMFBYCFCCX-KZVJFYERSA-N 0.000 description 1
- FSTWDRPCQQUJIT-NHCYSSNCSA-N Met-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCSC)N FSTWDRPCQQUJIT-NHCYSSNCSA-N 0.000 description 1
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- MPGJIHFJCXTVEX-KKUMJFAQSA-N Phe-Arg-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O MPGJIHFJCXTVEX-KKUMJFAQSA-N 0.000 description 1
- CGOMLCQJEMWMCE-STQMWFEESA-N Phe-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 CGOMLCQJEMWMCE-STQMWFEESA-N 0.000 description 1
- YYRCPTVAPLQRNC-ULQDDVLXSA-N Phe-Arg-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC1=CC=CC=C1 YYRCPTVAPLQRNC-ULQDDVLXSA-N 0.000 description 1
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 1
- QSWKNJAPHQDAAS-MELADBBJSA-N Phe-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O QSWKNJAPHQDAAS-MELADBBJSA-N 0.000 description 1
- YUPRIZTWANWWHK-DZKIICNBSA-N Phe-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N YUPRIZTWANWWHK-DZKIICNBSA-N 0.000 description 1
- IEIFEYBAYFSRBQ-IHRRRGAJSA-N Phe-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N IEIFEYBAYFSRBQ-IHRRRGAJSA-N 0.000 description 1
- 208000016012 Phenotypic abnormality Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- CYQQWUPHIZVCNY-GUBZILKMSA-N Pro-Arg-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O CYQQWUPHIZVCNY-GUBZILKMSA-N 0.000 description 1
- XROLYVMNVIKVEM-BQBZGAKWSA-N Pro-Asn-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O XROLYVMNVIKVEM-BQBZGAKWSA-N 0.000 description 1
- FUVBEZJCRMHWEM-FXQIFTODSA-N Pro-Asn-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FUVBEZJCRMHWEM-FXQIFTODSA-N 0.000 description 1
- UEHYFUCOGHWASA-HJGDQZAQSA-N Pro-Glu-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 UEHYFUCOGHWASA-HJGDQZAQSA-N 0.000 description 1
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 1
- STASJMBVVHNWCG-IHRRRGAJSA-N Pro-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)NC(=O)[C@H]1[NH2+]CCC1)C1=CN=CN1 STASJMBVVHNWCG-IHRRRGAJSA-N 0.000 description 1
- ULWBBFKQBDNGOY-RWMBFGLXSA-N Pro-Lys-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@H]2C(=O)O ULWBBFKQBDNGOY-RWMBFGLXSA-N 0.000 description 1
- AUYKOPJPKUCYHE-SRVKXCTJSA-N Pro-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@@H]1CCCN1 AUYKOPJPKUCYHE-SRVKXCTJSA-N 0.000 description 1
- LGMBKOAPPTYKLC-JYJNAYRXSA-N Pro-Phe-Arg Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(=N)N)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 LGMBKOAPPTYKLC-JYJNAYRXSA-N 0.000 description 1
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 1
- SNGZLPOXVRTNMB-LPEHRKFASA-N Pro-Ser-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N2CCC[C@@H]2C(=O)O SNGZLPOXVRTNMB-LPEHRKFASA-N 0.000 description 1
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 1
- DCHQYSOGURGJST-FJXKBIBVSA-N Pro-Thr-Gly Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O DCHQYSOGURGJST-FJXKBIBVSA-N 0.000 description 1
- VVAWNPIOYXAMAL-KJEVXHAQSA-N Pro-Thr-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VVAWNPIOYXAMAL-KJEVXHAQSA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- PZZJMBYSYAKYPK-UWJYBYFXSA-N Ser-Ala-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O PZZJMBYSYAKYPK-UWJYBYFXSA-N 0.000 description 1
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 1
- NRCJWSGXMAPYQX-LPEHRKFASA-N Ser-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)N)C(=O)O NRCJWSGXMAPYQX-LPEHRKFASA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 1
- YMDNFPNTIPQMJP-NAKRPEOUSA-N Ser-Ile-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(O)=O YMDNFPNTIPQMJP-NAKRPEOUSA-N 0.000 description 1
- MOINZPRHJGTCHZ-MMWGEVLESA-N Ser-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N MOINZPRHJGTCHZ-MMWGEVLESA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- XNCUYZKGQOCOQH-YUMQZZPRSA-N Ser-Leu-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O XNCUYZKGQOCOQH-YUMQZZPRSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 1
- XKFJENWJGHMDLI-QWRGUYRKSA-N Ser-Phe-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O XKFJENWJGHMDLI-QWRGUYRKSA-N 0.000 description 1
- QPPYAWVLAVXISR-DCAQKATOSA-N Ser-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QPPYAWVLAVXISR-DCAQKATOSA-N 0.000 description 1
- JCLAFVNDBJMLBC-JBDRJPRFSA-N Ser-Ser-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JCLAFVNDBJMLBC-JBDRJPRFSA-N 0.000 description 1
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 1
- DKGRNFUXVTYRAS-UBHSHLNASA-N Ser-Ser-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DKGRNFUXVTYRAS-UBHSHLNASA-N 0.000 description 1
- SOACHCFYJMCMHC-BWBBJGPYSA-N Ser-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N)O SOACHCFYJMCMHC-BWBBJGPYSA-N 0.000 description 1
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 1
- ATEQEHCGZKBEMU-GQGQLFGLSA-N Ser-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N ATEQEHCGZKBEMU-GQGQLFGLSA-N 0.000 description 1
- FRPNVPKQVFHSQY-BPUTZDHNSA-N Ser-Trp-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N FRPNVPKQVFHSQY-BPUTZDHNSA-N 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- MQCPGOZXFSYJPS-KZVJFYERSA-N Thr-Ala-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MQCPGOZXFSYJPS-KZVJFYERSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- CAJFZCICSVBOJK-SHGPDSBTSA-N Thr-Ala-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAJFZCICSVBOJK-SHGPDSBTSA-N 0.000 description 1
- NRUPKQSXTJNQGD-XGEHTFHBSA-N Thr-Cys-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NRUPKQSXTJNQGD-XGEHTFHBSA-N 0.000 description 1
- KWQBJOUOSNJDRR-XAVMHZPKSA-N Thr-Cys-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)N1CCC[C@@H]1C(=O)O)N)O KWQBJOUOSNJDRR-XAVMHZPKSA-N 0.000 description 1
- SLUWOCTZVGMURC-BFHQHQDPSA-N Thr-Gly-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O SLUWOCTZVGMURC-BFHQHQDPSA-N 0.000 description 1
- YZUWGFXVVZQJEI-PMVVWTBXSA-N Thr-Gly-His Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O YZUWGFXVVZQJEI-PMVVWTBXSA-N 0.000 description 1
- AYCQVUUPIJHJTA-IXOXFDKPSA-N Thr-His-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O AYCQVUUPIJHJTA-IXOXFDKPSA-N 0.000 description 1
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 1
- VGYVVSQFSSKZRJ-OEAJRASXSA-N Thr-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@H](O)C)CC1=CC=CC=C1 VGYVVSQFSSKZRJ-OEAJRASXSA-N 0.000 description 1
- IWAVRIPRTCJAQO-HSHDSVGOSA-N Thr-Pro-Trp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O IWAVRIPRTCJAQO-HSHDSVGOSA-N 0.000 description 1
- PRTHQBSMXILLPC-XGEHTFHBSA-N Thr-Ser-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PRTHQBSMXILLPC-XGEHTFHBSA-N 0.000 description 1
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 1
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- UDCHKDYNMRJYMI-QEJZJMRPSA-N Trp-Glu-Ser Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O UDCHKDYNMRJYMI-QEJZJMRPSA-N 0.000 description 1
- YTCNLMSUXPCFBW-SXNHZJKMSA-N Trp-Ile-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O YTCNLMSUXPCFBW-SXNHZJKMSA-N 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- VPRHDRKAPYZMHL-SZMVWBNQSA-N Trp-Leu-Glu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 VPRHDRKAPYZMHL-SZMVWBNQSA-N 0.000 description 1
- TUUXFNQXSFNFLX-XIRDDKMYSA-N Trp-Met-Glu Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N TUUXFNQXSFNFLX-XIRDDKMYSA-N 0.000 description 1
- WGBFZZYIWFSYER-BVSLBCMMSA-N Trp-Val-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N WGBFZZYIWFSYER-BVSLBCMMSA-N 0.000 description 1
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 1
- QHEGAOPHISYNDF-XDTLVQLUSA-N Tyr-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QHEGAOPHISYNDF-XDTLVQLUSA-N 0.000 description 1
- RYSNTWVRSLCAJZ-RYUDHWBXSA-N Tyr-Gln-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RYSNTWVRSLCAJZ-RYUDHWBXSA-N 0.000 description 1
- JWGXUKHIKXZWNG-RYUDHWBXSA-N Tyr-Gly-Gln Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N)O JWGXUKHIKXZWNG-RYUDHWBXSA-N 0.000 description 1
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 1
- YKCXQOBTISTQJD-BZSNNMDCSA-N Tyr-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N YKCXQOBTISTQJD-BZSNNMDCSA-N 0.000 description 1
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 1
- KKHRWGYHBZORMQ-NHCYSSNCSA-N Val-Arg-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKHRWGYHBZORMQ-NHCYSSNCSA-N 0.000 description 1
- SZTTYWIUCGSURQ-AUTRQRHGSA-N Val-Glu-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O SZTTYWIUCGSURQ-AUTRQRHGSA-N 0.000 description 1
- HQYVQDRYODWONX-DCAQKATOSA-N Val-His-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N HQYVQDRYODWONX-DCAQKATOSA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- OTJMMKPMLUNTQT-AVGNSLFASA-N Val-Leu-Arg Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](C(C)C)N OTJMMKPMLUNTQT-AVGNSLFASA-N 0.000 description 1
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 1
- SYSWVVCYSXBVJG-RHYQMDGZSA-N Val-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)N)O SYSWVVCYSXBVJG-RHYQMDGZSA-N 0.000 description 1
- ZRSZTKTVPNSUNA-IHRRRGAJSA-N Val-Lys-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)C(C)C)C(O)=O ZRSZTKTVPNSUNA-IHRRRGAJSA-N 0.000 description 1
- IEBGHUMBJXIXHM-AVGNSLFASA-N Val-Lys-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)N IEBGHUMBJXIXHM-AVGNSLFASA-N 0.000 description 1
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 1
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- HWNYVQMOLCYHEA-IHRRRGAJSA-N Val-Ser-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N HWNYVQMOLCYHEA-IHRRRGAJSA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- QPJSIBAOZBVELU-BPNCWPANSA-N Val-Tyr-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N QPJSIBAOZBVELU-BPNCWPANSA-N 0.000 description 1
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- GINJFDRNADDBIN-FXQIFTODSA-N bilanafos Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCP(C)(O)=O GINJFDRNADDBIN-FXQIFTODSA-N 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229940088530 claforan Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- FMGBNISRFNDECK-UHFFFAOYSA-N coronatine Natural products CCC1CC1(C(O)=O)NC(=O)C1=CC(CC)CC2C(=O)CCC12 FMGBNISRFNDECK-UHFFFAOYSA-N 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000023753 dehiscence Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000012215 gene cloning Methods 0.000 description 1
- 238000012214 genetic breeding Methods 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- JYPCXBJRLBHWME-UHFFFAOYSA-N glycyl-L-prolyl-L-arginine Natural products NCC(=O)N1CCCC1C(=O)NC(CCCN=C(N)N)C(O)=O JYPCXBJRLBHWME-UHFFFAOYSA-N 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000003617 indole-3-acetic acid Substances 0.000 description 1
- JTEDVYBZBROSJT-UHFFFAOYSA-N indole-3-butyric acid Chemical compound C1=CC=C2C(CCCC(=O)O)=CNC2=C1 JTEDVYBZBROSJT-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 108010089198 phenylalanyl-prolyl-arginine Proteins 0.000 description 1
- 230000026786 pollen maturation Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 230000005849 recognition of pollen Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000010153 self-pollination Effects 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 101150115529 tagA gene Proteins 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、DAD1(DEFECTIVE I
N ANTHER DEHISCENCE 1)遺伝子、及び該遺伝子の発現を
抑制した植物に関する。DAD1遺伝子は葯の裂開及び花粉
の成熟を制御する遺伝子であり、DAD1遺伝子の発現を抑
制することで、野生型に限りなく近い花器構造を有する
雄性不稔植物の作出を可能にする。作出された雄性不稔
植物はジャスモン酸、リノレン酸処理により稔性を回復
し、自殖種子を得ることができる。そのため、維持系統
を必要とせず、一代雑種品種育成が可能となる。The present invention relates to DAD1 (DEFECTIVE I
The present invention relates to a N ANTHER DEHISCENCE 1) gene and a plant in which the expression of the gene has been suppressed. The DAD1 gene is a gene that controls the cleavage of anthers and the maturation of pollen. By suppressing the expression of the DAD1 gene, it is possible to produce a male sterile plant having a flower organ structure as close as possible to the wild type. The male sterile plant thus produced can restore fertility by treatment with jasmonic acid and linolenic acid, and can obtain self-fertilized seeds. Therefore, it is possible to breed a first-generation hybrid variety without requiring a maintenance line.
【0002】[0002]
【従来の技術】近年、多くの作物で雑種強勢(ヘテロシ
ス)を利用した一代雑種(F1)品種の育成が進められてい
る。このF1品種のメリットは、雑種強勢の発現により収
量性、耐病性などの農業形質が優れたものとなること、
単因子優性の農業形質の付与が容易なこと、均一性が高
いこと、また、次世代で遺伝形質の分離が起こるため育
成者の権利が守られることなどが挙げられる。2. Description of the Related Art In recent years, breeding of hybrids of the first generation (F1) utilizing heterosis in many crops has been promoted. The advantage of this F1 cultivar is that the emergence of heterosis will lead to excellent agricultural traits such as yield, disease resistance,
It is easy to impart a single-factor dominant agricultural trait, has high uniformity, and protects the rights of breeders because the genetic traits are separated in the next generation.
【0003】F1品種においては、雑種第1代目の種子を
多量に確保する必要があり、そのための技術として、遺
伝的雄性不稔性を持つものを母親に使用することが行わ
れてきた。この他に自家不和合性を利用する方法、雄花
を人為的に除去する方法、人為的に交配する方法、など
があるが、これらの方法は利用できる植物種が限られて
いる。遺伝的雄性不稔性を利用する方法が、最も汎用性
に富んでいるため、F1種子を確保するために広く用いら
れてきた。[0003] In the F1 variety, it is necessary to secure a large amount of seeds of the first generation of hybrids, and as a technique therefor, it has been practiced to use those having genetic male sterility for mothers. In addition, there are a method of utilizing self-incompatibility, a method of artificially removing male flowers, a method of artificially crossing, and the like. However, these methods have limited available plant species. Methods utilizing genetic male sterility have been widely used to secure F1 seeds because they are the most versatile.
【0004】遺伝的な雄性不稔性には核内遺伝子によっ
て支配される雄性不稔性(GMS)と核遺伝子と細胞質因
子の両者が関与する細胞質雄性不稔性(CMS)の2種類があ
る。F1品種育成の際の採種においては、以下の理由から
CMSが利用されてきた。GMSの場合、雄性不稔性を示すの
は、その遺伝子についてホモ接合性の個体だけであり、
ヘテロ接合性の個体は通常稔性を持つ。効率的なF1種子
の生産を行うためには、母親に用いる個体すべてが雄性
不稔であることが求められるが、このことは、GMSを利
用してF1種子を生産する場合には、母親に用いる個体す
べてを雄性不稔性に関する遺伝子についてホモ接合性の
個体にしなければならないということを意味する。しか
し、GMSにおいては、それ自身の花粉が利用できないの
で自殖によるホモ接合性の個体を作出・維持出来ない。
ヘテロ接合性の個体を自家受粉することにより、ホモ接
合性の個体を作出することはできるが、この場合にはホ
モ接合性個体が1/4しか得られず、実用化できない。[0004] There are two types of genetic male sterility, male sterility (GMS) controlled by nuclear genes and cytoplasmic male sterility (CMS) involving both nuclear genes and cytoplasmic factors. . When breeding F1 varieties, for the following reasons
CMS has been used. In the case of GMS, only individuals homozygous for that gene show male sterility,
Heterozygous individuals usually have fertility. Efficient production of F1 seeds requires that all individuals used for mothers be male-sterile, which means that when GMS is used to produce F1 seeds, This means that all individuals used must be homozygous for the gene for male sterility. However, GMS cannot produce and maintain homozygous individuals by selfing because the pollen itself is not available.
Self-pollinating heterozygous individuals can produce homozygous individuals, but in this case, only 1/4 homozygous individuals are obtained and cannot be put to practical use.
【0005】しかし、GMSにおいても、その遺伝子に関
してホモ接合性の集団が得られる技術が開発されれば、
これを利用してF1種子の生産も可能になる。実際、雄性
不稔性のホモ接合性の個体を選抜する方法などが考案さ
れ、一部では利用されているが、ホモ接合性の集団を育
成する方法がなかった。[0005] However, in the case of GMS, if a technique for obtaining a population homozygous for the gene is developed,
Using this, the production of F1 seeds becomes possible. In fact, a method of selecting male-sterile homozygous individuals has been devised and used in some cases, but there has been no method for breeding a homozygous population.
【0006】[0006]
【発明が解決しようとする課題】本発明の目的は、葯の
裂開と花粉の成熟を制御する核遺伝子を提供すると共
に、その遺伝子発現を制御することによって、雄性不稔
性と雄性可稔性を制御して、母親に使用する植物集団の
個体全てが雄性不稔性となる技術を提供することであ
る。SUMMARY OF THE INVENTION It is an object of the present invention to provide a nuclear gene that controls anther dehiscence and pollen maturation, and that the gene expression is controlled to provide male sterility and male fertility. The purpose of the present invention is to provide a technique for controlling gender so that all individuals of a plant population used for mothers become male sterile.
【0007】[0007]
【課題を解決するための手段】本願発明者は、上記の課
題を解決すべく鋭意検討を重ねた結果、T-DNAタギング
法により、開花後も葯の裂開が起こらないシロイヌナズ
ナ(Arabidopsis thaliana)の突然変異体(dad1)の作出
に成功した。この変異体の花粉は、発芽能を失ってお
り、雄性不稔性であった。dad1突然変異体の蕾をジャス
モン酸あるいはリノレン酸で処理すると、その後開花し
た花では葯の裂開が見られ、自殖種子を形成した。この
dad1突然変異体より、T-DNA配列をもとにして、DAD1遺
伝子のゲノミッククローンとcDNAクローンを単離した。
単離したゲノミッククローンを植物導入ベクターに連結
して、dad1変異体に形質転換したところ、再生植物体で
は葯の裂開、自殖種子の形成が見られ、野生型表現型に
回復していた。この結果は、単離した遺伝子がDAD1遺伝
子であることを示すものである。さらに、DAD1のプロモ
ーターに逆向きに連結したアンチセンスDAD1遺伝子を植
物ゲノムDNA中に組み込むことによって、dad1突然変異
体同様に、葯の裂開の起こらない植物体を作出できるこ
とを見いだした。以上の知見に基づき、本発明は完成さ
れたものである。Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventor has found that the T-DNA tagging method does not cause anther dehiscence even after flowering, and Arabidopsis thaliana Mutant (dad1) was successfully created. The pollen of this mutant lost germination ability and was male sterile. When the buds of the dad1 mutant were treated with jasmonic acid or linolenic acid, the flowers that subsequently blossomed exhibited anther dehiscence and formed inbred seeds. this
Genomic and cDNA clones of the DAD1 gene were isolated from the dad1 mutant based on the T-DNA sequence.
When the isolated genomic clone was ligated to a plant transfer vector and transformed into a dad1 mutant, the regenerated plants showed anther dehiscence and self-seeded seed formation, and were restored to the wild-type phenotype. . This result indicates that the isolated gene is the DAD1 gene. Furthermore, it was found that by incorporating an antisense DAD1 gene reversely linked to the DAD1 promoter into plant genomic DNA, a plant body without anther dehiscence can be produced, similarly to the dad1 mutant. The present invention has been completed based on the above findings.
【0008】即ち、本発明の第一は、以下の(a)又は(b)
の塩基配列により表され、プロモーター活性を有するDN
Aに関するものである。 (a) 配列番号3に記載の塩基配列 (b) 配列番号3に記載の塩基配列において、1若しくは
複数の塩基が欠失、置換若しくは付加された塩基配列That is, the first aspect of the present invention is the following (a) or (b)
Having the promoter activity represented by the nucleotide sequence of
It is about A. (a) the base sequence of SEQ ID NO: 3 (b) the base sequence of SEQ ID NO: 3 in which one or more bases have been deleted, substituted or added
【0009】本発明の第二は、以下の(a)又は(b)のタン
パク質をコードするDNAに関するものである。 (a) 配列番号2に記載のアミノ酸配列により表されるタ
ンパク質 (b) 配列番号2に記載のアミノ酸配列において1若しく
は複数個のアミノ酸が欠失、置換若しくは付加されたア
ミノ酸配列により表され、葯の裂開を制御する機能を有
するタンパク質A second aspect of the present invention relates to a DNA encoding the following protein (a) or (b). (a) a protein represented by the amino acid sequence of SEQ ID NO: 2 (b) an amino acid sequence of SEQ ID NO: 2 wherein one or more amino acids are deleted, substituted or added, That have the function of controlling cleavage of DNA
【0010】本発明の第三は、上記第二発明のDNAと相
補的な塩基配列により表されるDNAに関するものであ
る。本発明の第四は、上記第二発明のDNAの発現が抑制
されていることを特徴とする雄性不稔植物に関するもの
である。本発明の第五は、上記第二発明のDNAの発現を
抑制することを特徴とする雄性不稔植物の作出方法に関
するものである。本発明の第六は、上記第四の発明の雄
性不稔植物をジャスモン酸、リノレン酸、又はそれらの
誘導体で処理することを特徴とする稔性回復方法に関す
るものである。A third aspect of the present invention relates to a DNA represented by a nucleotide sequence complementary to the DNA of the second aspect. A fourth aspect of the present invention relates to a male sterile plant, wherein the expression of the DNA of the second aspect is suppressed. A fifth aspect of the present invention relates to a method for producing a male sterile plant, which comprises suppressing the expression of the DNA of the second aspect. A sixth aspect of the present invention relates to a method for restoring fertility, comprising treating the male sterile plant of the fourth aspect with jasmonic acid, linolenic acid, or a derivative thereof.
【0011】[0011]
【発明の実施の形態】以下、本発明を詳細に説明する。 (1)第一発明 第一発明のDNAは、プロモーター活性を有するDNAであっ
て、配列番号3に記載の塩基配列又は配列番号3に記載
の塩基配列において、1若しくは複数の塩基が欠失若し
くは付加された塩基配列により表される。このような配
列番号3とは異なる塩基配列により表されるDNAとして
は、本願の出願時において常用される技術、例えば、部
位特異的突然変異誘発法(Zoller et al., Nucleic Aci
d Res. 10:6487-6500, 1982)によって変異を生じさせ
たDNAや配列番号3に記載の塩基配列により表されるDNA
と異なる遺伝子源から単離されたDNAなどを例示するこ
とができる。BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail. (1) First invention The DNA of the first invention is a DNA having a promoter activity, wherein one or more bases are deleted or deleted in the base sequence of SEQ ID NO: 3 or the base sequence of SEQ ID NO: 3. It is represented by the added base sequence. Such a DNA represented by a nucleotide sequence different from SEQ ID NO: 3 can be obtained by a technique commonly used at the time of filing the present application, for example, a site-directed mutagenesis method (Zoller et al., Nucleic Aci.
d Res. 10: 6487-6500, 1982) and DNA represented by the nucleotide sequence of SEQ ID NO: 3.
And DNA isolated from a different gene source.
【0012】第一発明のDNAは、実施例記載の方法によ
っても得ることが出来るが、その塩基配列は既に決定さ
れているので、この配列に基づきプライマーを合成し、
この遺伝子を含むDNAを鋳型にPCRを行うことによっても
得ることが出来る。使用するプライマーは、特に限定さ
れない。鋳型として用いるDNAとしては、プラスミドpGD
AD1-HS(このプラスミドを含む菌株は、工業技術院生命
工学工業技術研究所に受託番号FERM P-17299として寄託
されている)を挙げることが出来る。[0012] The DNA of the first invention can also be obtained by the method described in the Examples, but since its base sequence has already been determined, a primer is synthesized based on this sequence.
It can also be obtained by performing PCR using DNA containing this gene as a template. The primer used is not particularly limited. As the DNA used as a template, plasmid pGD
AD1-HS (a strain containing this plasmid has been deposited with the National Institute of Advanced Industrial Science and Technology under the accession number FERM P-17299).
【0013】(2)第二発明 第二発明のDNAは、配列番号2に記載のアミノ酸配列に
より表されるタンパク質、又は配列番号2に記載のアミ
ノ酸配列において、一若しくは複数のアミノ酸配列が欠
失、置換若しくは付加されたアミノ酸配列により表さ
れ、葯の裂開を制御する機能を有するタンパク質をコー
ドする。このような配列番号2とは異なるアミノ酸配列
をコードするDNAとしては、本願の出願時において常用
される技術、例えば、部位特異的突然変異誘発法(Zoll
er et al., Nucleic Acid Res. 10:6487-6500, 1982)
によって変異を生じさせたDNAや配列番号2に記載のア
ミノ酸配列をコードするDNAと異なる遺伝子源から単離
されたDNAなどを例示することができる。なお、配列番
号2に記載のアミノ酸配列により表されるタンパク質を
コードするDNAは、WSエコタイプのシロイヌナズナのゲ
ノミックライブラリーから単離されたものであるが、Le
rエコタイプのシロイヌナズナのcDNAライブラリーから
単離されたDNAは、配列番号2の13〜15番目のVal-Val-V
alに更にもう一つのValが付加された配列をコードする
ものであった。上記の趣旨より、このようなDNAも第二
発明のDNAに含まれるのはいうまでもない。(2) Second invention The DNA of the second invention is a protein represented by the amino acid sequence of SEQ ID NO: 2 or the amino acid sequence of SEQ ID NO: 2 in which one or more amino acid sequences are deleted. Encodes a protein represented by a substituted or added amino acid sequence and having a function of controlling anther dehiscence. Such a DNA encoding an amino acid sequence different from SEQ ID NO: 2 can be obtained by a technique commonly used at the time of filing the present application, for example, site-directed mutagenesis (Zoll
er et al., Nucleic Acid Res. 10: 6487-6500, 1982)
And DNA isolated from a gene source different from the DNA encoding the amino acid sequence set forth in SEQ ID NO: 2, and the like. The DNA encoding the protein represented by the amino acid sequence set forth in SEQ ID NO: 2 was isolated from a genomic library of Arabidopsis thaliana of WS ecotype.
r DNA isolated from the ecotype Arabidopsis thaliana cDNA library is Val-Val-V at positions 13 to 15 of SEQ ID NO: 2.
It encoded a sequence in which another Val was added to al. Needless to say, such a DNA is also included in the DNA of the second invention from the above-mentioned purpose.
【0014】あるDNAが葯の裂開を制御する機能を持つ
かどうかは、そのDNAを、内在のDAD1の発現が抑制され
た植物(例えば、実施例2に記載した「dad1」)に導入
し、それにより葯の裂開が回復するかどうかを調べるこ
とにより判断できる。第二発明のDNAは、実施例記載の
方法によっても得ることが出来るが、その塩基配列は既
に決定されているので、この配列に基づきプライマーを
合成し、この遺伝子を含むDNAを鋳型にPCRを行うことに
よっても得ることが出来る。使用するプライマーは、特
に限定されない。鋳型として用いるDNAとしては、上記
のプラスミドpGDAD1-HSを挙げることが出来る。[0014] Whether a certain DNA has a function of controlling the cleavage of anthers is determined by introducing the DNA into a plant in which the expression of endogenous DAD1 is suppressed (for example, "dad1" described in Example 2). It can be determined by examining whether or not the anther dehiscence is restored. The DNA of the second invention can also be obtained by the method described in Examples, but since the base sequence has already been determined, a primer is synthesized based on this sequence, and PCR is performed using DNA containing this gene as a template. It can also be obtained by performing. The primer used is not particularly limited. Examples of the DNA used as a template include the above plasmid pGDAD1-HS.
【0015】(3)第三発明 第三発明のDNAは、上記第二発明のDNAと相補的な塩基配
列により表される。第三発明のDNAは、実施例記載の方
法によっても得ることが出来るが、その塩基配列は配列
表に記載した配列から容易に求めることができるので、
この配列に基づきプライマーを合成し、この遺伝子を含
むDNAを鋳型にPCRを行うことによっても得ることが出来
る。使用するプライマーは、特に限定されない。鋳型と
して用いるDNAとしては、上記のプラスミドpGDAD1-HSを
挙げることが出来る。(3) Third Invention The DNA of the third invention is represented by a nucleotide sequence complementary to the DNA of the second invention. Although the DNA of the third invention can be obtained by the method described in the Examples, since its base sequence can be easily obtained from the sequence described in the sequence listing,
It can also be obtained by synthesizing a primer based on this sequence and performing PCR using DNA containing this gene as a template. The primer used is not particularly limited. Examples of the DNA used as a template include the above plasmid pGDAD1-HS.
【0016】(4)第四発明 第四発明の雄性不稔植物は、第二発明のDNAの発現が抑
制されていることを特徴とするものである。植物の種類
は、第二発明のDNAを有するものであれば特に限定され
ず、例えば、アブラナ科、イネ科、キク科、アカザ科の
植物などを挙げることができる。(4) Fourth Invention The male sterile plant of the fourth invention is characterized in that the expression of the DNA of the second invention is suppressed. The type of plant is not particularly limited as long as it has the DNA of the second invention, and includes, for example, plants of the Brassicaceae, Poaceae, Compositae, Acalyptaceae and the like.
【0017】この雄性不稔の植物の特徴点としては、以
下の2点を挙げることができる。一つは、葯が裂開しな
い他は、その形質は野生型のそれとほとんど変わりがな
い点である。雄性不稔性を利用したF1採種は、例えば、
アブラナ科野菜では数例しか報告がない。これは、従来
の雄性不稔系統の多くに花器の異常が見られるため、送
粉昆虫が訪花せず採種量が少ないためである。本発明の
雄性不稔植物は、その花器官が野生型に限りなく近いた
めに、ハチやアブ等の送粉昆虫の訪花を容易にし、採種
量の増大を図ることができる。この植物の他の一つの特
徴点は、リノレン酸やジャスモン酸などで処理すること
によってその稔性を回復させることができる点である。
本発明の雄性不稔植物は、このような性質から容易に自
殖種子が得られ、雄性不稔遺伝子ホモ接合性の集団を容
易に作製することが出来る。この雄性不稔植物は、例え
ば、後述する第五発明の作出方法に従って作出すること
ができる。The following two points can be cited as characteristics of the male-sterile plant. One is that the trait is almost identical to that of the wild type, except that the anthers do not cleave. F1 seed utilizing male sterility, for example,
There are only a few reports of cruciferous vegetables. This is because many of the conventional male sterile lines have abnormal flower organs, so that pollinating insects do not visit flowers and the seeding amount is small. The male sterile plant of the present invention has a flower organ as close as possible to the wild type, so that it is easy to visit flowers of pollinating insects such as bees and flies, and it is possible to increase the seeding amount. Another feature of this plant is that its fertility can be restored by treatment with linolenic acid or jasmonic acid.
The male sterile plant of the present invention can easily obtain self-fertile seeds from such properties, and can easily produce a population of male sterile gene homozygous. This male sterile plant can be produced, for example, according to the production method of the fifth invention described below.
【0018】(5)第五発明 第五発明の作出方法は、第二発明のDNAの発現を抑制す
ることを特徴とするものである。第二発明のDNAの発現
を抑制する方法は、特に限定されないが、好ましい方法
として、以下のアンチセンス法、コ・サプレッション
法、遺伝子破壊型タギング法、ジーンターゲティング
法、突然変異誘発源を利用する方法などを例示すること
ができる。(5) Fifth Invention The production method of the fifth invention is characterized in that the expression of the DNA of the second invention is suppressed. The method for suppressing the expression of the DNA of the second invention is not particularly limited, but preferred methods include the following antisense method, co-suppression method, gene disruption tagging method, gene targeting method, and mutagen source. Methods and the like can be exemplified.
【0019】i) アンチセンス法 この方法は、適当なプロモータとその下流に配置された
第三発明のDNA(アンチセンスDNA)とを含むベクターを
構築し、それを植物に導入することにより、第二発明の
DNAの発現を抑制する方法である。ここで使用するプロ
モーターとしては、第一発明のDNA(プロモーター)が
好ましいが、他のプロモーターを用いても良い。他のプ
ロモーターとしては、CaMV35Sプロモーターなどの公知
の植物発現プロモーターを用いることができる。I) Antisense method This method comprises the steps of constructing a vector containing an appropriate promoter and the DNA of the third invention (antisense DNA) arranged downstream thereof and introducing the vector into a plant. Two inventions
This is a method for suppressing the expression of DNA. As the promoter used here, the DNA (promoter) of the first invention is preferable, but another promoter may be used. As other promoters, known plant expression promoters such as the CaMV35S promoter can be used.
【0020】ベクターの植物への導入は、植物細胞へ外
来遺伝子を導入する際に常用する方法、例えば、アグロ
バクテリウムを用いた方法により行うことが出来る。ア
グロバクテリウムとしては、植物の外来遺伝子導入に常
用されるものであれば特に限定されないが、例えば、Ag
robacterium tumefacience EHA101株(Hood et al.,J.
Bacteriol. 168:1291-1301 1986)を用いることができ
る。The introduction of the vector into the plant can be performed by a method commonly used when introducing a foreign gene into a plant cell, for example, a method using Agrobacterium. The Agrobacterium is not particularly limited as long as it is commonly used for introducing a foreign gene into a plant.
robacterium tumefacience strain EHA101 (Hood et al., J.
Bacteriol. 168: 1291-1301 1986) can be used.
【0021】プロモーターと共に導入された第三発明の
DNAは、植物内で第二発明のDNAに対するアンチセンス遺
伝子としてはたらく。即ち、第三発明のDNAの転写産物
が、植物内にもともと存在する第二発明のDNAの転写産
物と対合し、その翻訳を阻害し、その結果、第二発明の
DNAの発現が抑制される。植物体に第三発明のDNAが導入
されているかどうかは、植物体よりゲノムDNAを抽出
し、サザンハイブリダイゼーションを行うことにより確
認できる。The third invention introduced together with the promoter
The DNA acts as an antisense gene for the DNA of the second invention in the plant. That is, the transcript of the DNA of the third invention is paired with the transcript of the DNA of the second invention originally present in the plant, and inhibits the translation thereof.
DNA expression is suppressed. Whether or not the DNA of the third invention has been introduced into the plant can be confirmed by extracting genomic DNA from the plant and performing Southern hybridization.
【0022】ii) コ・サプレッション法 この方法は、第一発明のDNA(プロモーター)の下流に
任意の遺伝子を配置したベクターを構築し、これを植物
に導入することにより、コ・サプレッションを起こさ
せ、これにより第二発明のDNAの発現を抑制する方法で
ある。第一発明のDNAの下流に連結する遺伝子は、特に
限定されず、例えば、GUSレポーター遺伝子、第二発明
のDNA等を使用することが出来る。ベクターの植物への
導入は、上記のアンチセンス法と同様に行うことができ
る。Ii) Co-suppression method In this method, a vector having an arbitrary gene arranged downstream of the DNA (promoter) of the first invention is constructed and introduced into a plant to cause co-suppression. This is a method for suppressing the expression of the DNA of the second invention. The gene linked downstream of the DNA of the first invention is not particularly limited, and for example, a GUS reporter gene, the DNA of the second invention, and the like can be used. Vectors can be introduced into plants in the same manner as in the antisense method described above.
【0023】iii) 遺伝子破壊型タギング法 この方法は、T-DNAまたはトランスポゾンを第二発明のD
NAに挿入することにより、第二発明のDNAの発現を抑制
する方法である。T-DNAやトランスポゾンを含むベクタ
ーを植物に導入することにより、T-DNAやトランスポゾ
ンがゲノム中にランダムに挿入した突然変異系統群を作
製する。これら系統群の植物体からゲノムDNAを調製
し、PCR法を利用してDAD1の遺伝子破壊株をスクリーニ
ングすることができる。あるいはこれらの系統群の植物
体の表現形を観察して葯の裂開していない変異体を選抜
し、蕾にリノレン酸やジャスモン酸を処理することによ
り、DAD1遺伝子破壊株を選抜することができる。Iii) Gene disruption type tagging method This method uses the T-DNA or transposon to
This is a method for suppressing the expression of the DNA of the second invention by inserting it into NA. By introducing a vector containing a T-DNA or transposon into a plant, a mutant strain group in which the T-DNA or transposon is randomly inserted into the genome is created. Genomic DNA can be prepared from the plants of these lineage groups, and the DAD1 gene-disrupted strain can be screened using PCR. Alternatively, by observing the phenotypes of the plants of these lineages, selecting mutants without anther dehiscence, and treating buds with linolenic acid or jasmonic acid to select DAD1 gene-disrupted strains. it can.
【0024】T-DNAタギングに用いるベクターは、特に
限定されず、例えば、pBIH1-IGを使用することができ
る。また、トランスポゾンタギングに使用するトランス
ポゾンについては、特に限定されず、例えば、Ac-Ds系
等のDNA型トランスポゾンや、レトロトランスポゾンを
使用することができる。The vector used for T-DNA tagging is not particularly limited, and for example, pBIH1-IG can be used. The transposon used for transposon tagging is not particularly limited, and for example, a DNA-type transposon such as an Ac-Ds system or a retrotransposon can be used.
【0025】iv) ジーンターゲティング法 この方法は、相同組換えにより第二発明のDNAの一部に
他のDNAを挿入し、第二発明のDNAをノックアウトするこ
とにより第二発明のDNAの発現を抑制する方法である。
このような第二発明のDNAをノックアウトする方法とし
ては、例えば、Kempinらの方法(Kempin et al. Nature
389: 802-803. 1997)に従って行うことができる。即
ち、第二発明のDNA内にカナマイシン遺伝子等を挿入し
たターゲティングベクターを作製し、これを植物に導入
し、相同組換えを起こさせ、第二発明のDNAをノックア
ウトする。相同組換えが起こったかどうかは、PCRやサ
ザンハイブリダイゼーションにより確認することができ
る。Iv) Gene targeting method In this method, the DNA of the second invention is expressed by inserting another DNA into a part of the DNA of the second invention by homologous recombination and knocking out the DNA of the second invention. It is a method of suppressing.
As a method for knocking out the DNA of the second invention, for example, the method of Kempin et al. (Kempin et al. Nature
389: 802-803. 1997). That is, a targeting vector in which a kanamycin gene or the like is inserted into the DNA of the second invention is prepared, and this is introduced into a plant to cause homologous recombination to knock out the DNA of the second invention. Whether or not homologous recombination has occurred can be confirmed by PCR or Southern hybridization.
【0026】v) 突然変異誘発源を利用した方法 この方法は、突然変異誘発源を処理し、第二発明のDNA
に突然変異を起こすことにより、第二発明のDNAの発現
を抑制する方法である。対象植物の種子もしくは植物体
に誘発源を処理し、処理当代(M1)を自殖した世代(M
2)の植物体からDAD1遺伝子破壊株を選抜することがで
きる。例えば、数千の個体を突然変異誘発源で処理した
後、これらの自殖種子を採種する。M1世代1個体あたり
数粒の種子を圃場に植えて観察して葯の裂開していない
変異体を選抜する。選抜した個体の蕾にリノレン酸やジ
ャスモン酸を処理することにより、DAD1遺伝子破壊株を
選抜することができる。V) Method Using Mutagen Source This method comprises treating the mutagen and treating the DNA of the second invention.
This is a method for suppressing the expression of the DNA of the second invention by causing a mutation in the DNA. The generation (M1) in which the seed or plant body of the target plant is treated with the induction source and the current generation (M1) is selfed
A DAD1 gene-disrupted strain can be selected from the plant of 2). For example, after treating thousands of individuals with a mutagen, these inbred seeds are harvested. Several seeds per M1 generation are planted in a field and observed to select mutants without anther dehiscence. By treating the buds of the selected individual with linolenic acid or jasmonic acid, a DAD1 gene-disrupted strain can be selected.
【0027】用いる突然変異誘発源は、突然変異率を高
める誘発源としてよく用いられるものであれば特に限定
されないが、例えば、X線およびγ線、メタンスルホン
酸エチル(EMS)、N−ニトロソ−N−メチルウレア(NM
U)を使用することができる。上記のiii)、iv)、v)の方
法により雄性不稔化させた植物は、第二発明のDNAを正
常に発現する植物との交配により次代(F1)で稔性を回
復するので、F1植物の種子を農産物として利用する植
物、例えば、ナタネ、イネ、オオムギ、コムギ等一般作
物のF1採種に有効である。The mutagen to be used is not particularly limited as long as it is commonly used as a mutagen to increase the mutation rate. For example, X-rays and gamma rays, ethyl methanesulfonate (EMS), N-nitroso- N-methylurea (NM
U) can be used. The plant that has been male-sterilized by the methods iii), iv) and v) restores fertility in the next generation (F1) by crossing with a plant that normally expresses the DNA of the second invention. It is effective for F1 seeding of plants that use plant seeds as agricultural products, for example, general crops such as rapeseed, rice, barley, and wheat.
【0028】(6)第六発明 第六の発明の稔性回復方法は、上記第四発明の雄性不稔
植物をジャスモン酸、リノレン酸、又はそれらの誘導体
で処理することを特徴とするものである。ジャスモン酸
及びリノレン酸の誘導体としては、例えば、ジャスモン
酸メチル、リノレン酸ナトリウム、12-オキソ‐フィト
ジェン酸、コロナチン等を挙げることができるが、これ
らに限定されるわけではない。(6) Sixth invention The method for restoring fertility according to the sixth invention is characterized in that the male sterile plant according to the fourth invention is treated with jasmonic acid, linolenic acid, or a derivative thereof. is there. Examples of the derivatives of jasmonic acid and linolenic acid include, but are not limited to, methyl jasmonate, sodium linolenate, 12-oxo-phytogenic acid, coronatine, and the like.
【0029】処理方法としては、蕾をジャスモン酸等を
含む溶液に浸漬する方法を例示することができるが、こ
れ以外にも例えば、筆、スプレーなどを使用して処理し
てもよい。ジャスモン酸等を含む溶液の濃度及び浸漬時
間は、特に限定されないが、ジャスモン酸メチルの場
合、0.05〜0.5mMの溶液に数秒間浸漬するのが好まし
い。As a treatment method, a method of immersing the buds in a solution containing jasmonic acid or the like can be exemplified. Alternatively, the buds may be treated with a brush, spray, or the like. The concentration and the immersion time of the solution containing jasmonic acid and the like are not particularly limited, but in the case of methyl jasmonate, it is preferable to immerse in a 0.05 to 0.5 mM solution for several seconds.
【0030】[0030]
【実施例】以下、本発明について実施例を挙げて詳細に
説明するが、この実施例は、本発明の範囲を限定するも
のではない。 [実施例1] dad1変異体の作出 (1)シロイヌナズナ・ゲノムDNAへの T-DNAの挿入 T-DNAタギングを行うため、タギングベクターpBIH1-IG
(名古屋大学・中村研三教授より供与、図1)をアグロ
バクテリウム用いて、シロイヌナズナへ導入した。シロ
イヌナズナへの遺伝子導入はモデル植物の実験プロトコ
ール(秀潤社 p99-104)に従い、以下のように行った。
シロイヌナズナ(WSエコタイプ、京都大学大学院理学研
究科 植物学教室)の芽ばえから胚軸部分を切り取り、
2,4-ジクロロフェノキシ酢酸(0.5mg/L)とカイネチン
(0.05mg/L)を含むCIM培地で培養し、胚軸の切り口にカ
ルスを誘導した。このカルスに、pBIH1-IGを含むアグロ
バクテリウム EHA101 株を感染させ、pBIH1-IGの T-DNA
をカルス細胞のゲノムに導入した。EXAMPLES Hereinafter, the present invention will be described in detail with reference to examples, but the examples do not limit the scope of the present invention. [Example 1] Production of dad1 mutant (1) Insertion of T-DNA into Arabidopsis genomic DNA To perform T-DNA tagging, a tagging vector pBIH1-IG
(Provided by Prof. Kenzo Nakamura, Nagoya University, Fig. 1) was introduced into Arabidopsis thaliana using Agrobacterium. Gene transfer into Arabidopsis was carried out as follows in accordance with the experimental protocol of a model plant (Shujunsha p99-104).
Cut off the hypocotyl from the seedlings of Arabidopsis thaliana (WS ecotype, Department of Botany, Kyoto University Graduate School of Science)
2,4-dichlorophenoxyacetic acid (0.5mg / L) and kinetin
(0.05 mg / L), and callus was induced at the cut end of the hypocotyl. This callus was infected with Agrobacterium EHA101 strain containing pBIH1-IG, and the T-DNA of pBIH1-IG was
Was introduced into the callus cell genome.
【0031】(2)形質転換シロイヌナズナ植物体の再
生 T-DNA が導入されたカルスをカナマイシン(50mg/L)、
ハイグロマイシン B(20mg/L)、バンコマイシン(500m
g/L)およびクラフォラン(200mg/L)を含むSIM培地(5
mg/L 2-イソペンテニルアデニンと0.15mg/Lインドール
酢酸)上で選抜しながらシュートを誘導した。シュート
を切り取り、0.02mg/Lインドール酪酸を含むRIM培地に
移し、発根を誘導した。このようにしてできた再生植物
体(T1世代)をバーミキュライトに植えかえ、蛍光灯下
で栽培した。自家受粉によって種子(T2世代)を形成さ
せ、採種した。(2) Regeneration of Transformed Arabidopsis thaliana Callus into which T-DNA was introduced was transformed with kanamycin (50 mg / L),
Hygromycin B (20mg / L), vancomycin (500m
g / L) and claforan (200 mg / L)
Shoots were induced while selection on (mg / L 2-isopentenyl adenine and 0.15 mg / L indole acetic acid). Shoots were excised and transferred to a RIM medium containing 0.02 mg / L indolebutyric acid to induce rooting. The regenerated plant (T1 generation) thus produced was replanted in vermiculite and cultivated under fluorescent light. Seeds (T2 generation) were formed by self-pollination and collected.
【0032】[実施例2] dad1変異体の同定と解析 (1)dad1突然変異体の同定 T2世代の種子をバーミキュライトに播種し、蛍光灯下で
栽培した。開花後も葯が裂開しない個体を見いだし、da
d1と命名した(図2)。dad1個体の花の雌しべに非形質
転換体シロイヌナズナ(WSエコタイプ)の花粉を1回目
戻し交配を行い、 F1 種子を得た。育成した植物の表現
型は野生型であり、dad1突然変異体は劣性突然変異であ
ることが分かった。F1植物から自殖種子(F2)を採種し
た後、F2植物集団の中に現れた dad1 変異体に対し、同
様の方法で2回目の戻し交配を行い、F2種子を得た。こ
の F2 集団の中からdad1表現型を示す個体を選び、以下
の解析に用いた。Example 2 Identification and Analysis of dad1 Mutant (1) Identification of dad1 Mutant T2 generation seeds were sown on vermiculite and cultivated under fluorescent light. An individual whose anther does not cleave after flowering is found, and da
It was named d1 (Fig. 2). Pollen of the non-transformed Arabidopsis thaliana (WS ecotype) was first backcrossed to the pistil of the flower of dad1 individual to obtain F1 seed. The phenotype of the grown plants was wild type, and the dad1 mutant was found to be a recessive mutation. After collecting self-fertilized seeds (F2) from the F1 plants, the dad1 mutants that appeared in the F2 plant population were backcrossed a second time in the same manner to obtain F2 seeds. Individuals exhibiting the dad1 phenotype were selected from this F2 population and used for the following analyses.
【0033】(2)リノレン酸およびジャスモン酸によ
る変異の回復 dad1変異体の花序のうち、まだ開花していないつぼみが
付いている部分を0.05%リノレン酸ナトリウム水溶液ま
たは 0.5 mM ジャスモン酸メチル水溶液(0.05% Tween
20 を含む)に浸したところ、その後開花した 10個程度
の花で葯の裂開が見られ(図2)、自殖種子が形成され
た。この種子を取って土に播き、育てたところ、すべて
の個体が dad1 表現型を示した。(2) Recovery of Mutation by Linolenic Acid and Jasmonic Acid Among the inflorescences of the dad1 mutant, those portions with buds that have not yet bloomed are replaced with a 0.05% aqueous solution of sodium linolenate or a 0.5 mM aqueous solution of methyl jasmonate (0.05%). % Tween
20) (see Fig. 2), anther dehiscence was observed in about 10 flowers that subsequently blossomed (Fig. 2), and selfed seeds were formed. When these seeds were taken, sown on the soil and raised, all individuals exhibited the dad1 phenotype.
【0034】[実施例3] DAD1遺伝子のクローニング (1)IPCR(inverse PCR)によるT-DNA 隣接領域の単
離 dad1突然変異体から調製したゲノミックDNAをEcoRIで切
断し、T4リガーゼで環状化した。ゲノム中に挿入されて
いる T-DNA(バイナリーベクター pBIH1-IG 由来の T-D
NA)のレフトボーダー側に対応する2個のプライマー HP
H-R(5'-TTTGCCCTCGGACGAGTGCT-3')および L6(5'-CAG
CACATCCCCCTTTCGCCAG-3')を用いてPCRを行い、T-DNA
のレフトボーダーに隣接した遺伝子 Aの一部(0.5 kbの
DNA断片)を単離した。[Example 3] Cloning of DAD1 gene (1) Isolation of T-DNA flanking region by IPCR (inverse PCR) Genomic DNA prepared from dad1 mutant was cut with EcoRI and circularized with T4 ligase. . T-DNA inserted into the genome (TD derived from the binary vector pBIH1-IG
Two primers HP corresponding to the left border side of NA)
HR (5'-TTTGCCCTCGGACGAGTGCT-3 ') and L6 (5'-CAG
Perform PCR using CACATCCCCCTTTCGCCAG-3 ') and obtain T-DNA
Part of gene A (0.5 kb) adjacent to the left border of
DNA fragment) was isolated.
【0035】(2)ゲノミッククローンの単離 (1)で単離したDNA断片(遺伝子 Aの一部)を32P で
標識してプローブに用い、lambda DASH II(Stratagene
社)をベクターに用いて作製したシロイヌナズナ(WSエ
コタイプ)のゲノミックライブラリをスクリーニング
し、遺伝子 Aを含むゲノミッククローン lambda 2-1a-1
を単離した(図3)。(2) Isolation of genomic clone The DNA fragment (part of gene A) isolated in (1) was labeled with 32 P and used as a probe, and used as a probe in lambda DASH II (Stratagene).
Genomic clone lambda 2-1a-1 containing genomic A
Was isolated (FIG. 3).
【0036】(3)ゲノミッククローンのプラスミドへ
のサブクローニングと塩基配列の決定(図3) lambda 2-1a-1 を HindIIIで切断して得た 3.9 kb の遺
伝子断片と EcoRIで切断して得た 5.8 kb の遺伝子断片
をそれぞれプラスミドベクター pBluescript SK+(Stra
tagene社)につなぎ、遺伝子 Aの 5' 側部分のサブクロ
ーン pAKH3.9と3' 側部分のサブクローン pAKE5.8を作
製した。次に pAKH3.9を HindIIIと EcoRIで切断して得
た断片と pAKE5.8を EcoRIと SplI で切断して得た断片
を連結してプラスミドベクター pBluescript SK+(Stra
tagene社)につなぎ、遺伝子 AのHindIIIから SplI ま
での領域をプラスミド上に再構築した。このプラスミド
をpGDAD1-HSと名付けた。このプラスミドを用いて、遺
伝子 Aの HindIIIから SplI までの領域の塩基配列を決
定した。なお、遺伝子Aを含むプラスミドpGDAD1-HSは、
大腸菌に導入された状態で工業技術院生命工学工業技術
研究所に受託番号FERN P-17299として寄託されている
(寄託日:平成11年3月12日)。(3) Subcloning of genomic clone into plasmid and determination of nucleotide sequence (FIG. 3) 3.9 kb gene fragment obtained by cutting lambda 2-1a-1 with HindIII and 5.8 obtained by cutting with EcoRI. Each of the kb gene fragments was transferred to a plasmid vector pBluescript SK + (Stra
tagA) and a subclone pAKH3.9 at the 5 ′ side of gene A and a subclone pAKE5.8 at the 3 ′ side were prepared. Next, a fragment obtained by digesting pAKH3.9 with HindIII and EcoRI and a fragment obtained by digesting pAKE5.8 with EcoRI and SplI were ligated and the plasmid vector pBluescript SK + (Stra
tagene) and the region from HindIII to SplI of gene A was reconstructed on a plasmid. This plasmid was named pGDAD1-HS. Using this plasmid, the nucleotide sequence of the region from HindIII to SplI of gene A was determined. The plasmid pGDAD1-HS containing gene A is
Deposited in Escherichia coli and deposited with the National Institute of Advanced Industrial Science and Technology under the accession number FERN P-17299 (Deposit date: March 12, 1999).
【0037】(4)cDNAクローンの単離と塩基配列の決
定 lambda 2-1a-1 を SpeI で切断して得られる3.6 kbの D
NA断片を32P で標識してプローブに用い、lambda ZAP I
I(Stratagene社)をベクターに用いて作製したシロイ
ヌナズナ(Ler エコタイプ)の花芽の cDNA ライブラリ
ーをスクリーニングし、遺伝子 Aの cDNAクローン lamb
da 5a3 を単離した。その塩基配列解析したところ、こ
のクローンは 3' 側を欠いていることが明らかになった
ので、プライマーDAD1-FP3(5'-CTCCTTGAGAAGCAAGGCACG
AAG-3')を用いて 3'-RACE法を行い、欠けていた部分を
単離した。得られた全長のcDNAクローンは、448アミノ
酸残基よりなるタンパク質をコードするオープンリーデ
ィングフレームを含んでいた。ゲノミッククローンの塩
基配列とcDNAクローンの塩基配列の比較より、遺伝子A
はイントロンを含まないことが明らかになった。また、
cDNAクローンのオープンリーディングフレームはゲノミ
ッククローンのオープンリーディングフレームより3bp
長く、コードするタンパク質のN末端付近に余分に1ア
ミノ酸残基が挿入されていることがわかったが、この差
はクローンがそれぞれ由来するLerとWSのエコタイプの
違いに起因するものであり、コードするタンパク質の活
性には関係がないと推定した。(4) Isolation of cDNA Clone and Determination of Nucleotide Sequence A 3.6 kb D fragment obtained by digesting lambda 2-1a-1 with SpeI.
The NA fragment was labeled with 32 P and used as a probe.
A cDNA library of Arabidopsis thaliana (Ler ecotype) flower buds prepared using I (Stratagene) as a vector was screened.
da 5a3 was isolated. Analysis of its nucleotide sequence revealed that this clone lacked the 3 'side, and thus primer DAD1-FP3 (5'-CTCCTTGAGAAGCAAGGCACG
AAG-3 ') was used to perform the 3'-RACE method, and the missing portion was isolated. The resulting full-length cDNA clone contained an open reading frame encoding a protein consisting of 448 amino acid residues. From the comparison of the nucleotide sequence of the genomic clone and the cDNA clone, the gene A
Was found to contain no introns. Also,
The open reading frame of the cDNA clone is 3 bp from the open reading frame of the genomic clone.
It was found that one extra amino acid residue was inserted near the N-terminus of the encoded protein. It was assumed that the activity of the encoded protein was unrelated.
【0038】[実施例4] 相補性実験(遺伝子 Aが D
AD1 遺伝子であることの確認) pGDAD1-HS を SpeI で切断し、切り出した 3651 bpの D
NA断片(配列番号1の一部)を pBI101 由来のバイナリ
ーベクター pARK5-MCS(明治製菓(株)より供与された
プラスミド pARK5を一部改変)の SmaI 部位に連結し
て、バイナリープラスミド pTDAD1-SS(図4)を作製し
た。このプラスミドを Agrobacterium tumefacience C5
8C1 (pGV2260) 株に導入した。リノレン酸処理によって
得た dad1突然変異体の自殖種子から実施例1−(1)
と同様の方法でカルスを調製し、pTDAD1-SS を含む上記
アグロバクテリウムを感染させて、遺伝子 Aを含む Spe
I 断片を挿入した T-DNAをdad1変異体由来のカルスのゲ
ノムに導入した。このカルスをビアラホス(10 mg/L)
(明治製菓(株)より供与)で選抜しながら実施例1−
(2)と同様の方法で培養し、再生植物体を形成させ
た。この再生植物体を土に移して栽培し、開花させたと
ころ、葯の裂開と、自殖種子の形成が見られ、野生型表
現型に回復していることが確認できた。この結果より、
最終的に遺伝子 Aが DAD1 遺伝子であると同定した。Example 4 Complementation Experiment (Gene A is D
Confirmation of AD1 gene) pGDAD1-HS was cut with SpeI, and the cut out 3651 bp D
The NA fragment (part of SEQ ID NO: 1) was ligated to the SmaI site of the pBI101-derived binary vector pARK5-MCS (partially modified from plasmid pARK5 provided by Meiji Seika Co., Ltd.), and the binary plasmid pTDAD1-SS ( FIG. 4) was produced. This plasmid is transferred to Agrobacterium tumefacience C5
8C1 (pGV2260) strain. Example 1- (1) from inbred seed of dad1 mutant obtained by linolenic acid treatment
Callus was prepared in the same manner as described above, and infected with the above Agrobacterium containing pTDAD1-SS, and Spe containing gene A was
The T-DNA into which the I fragment was inserted was introduced into the genome of the callus derived from the dad1 mutant. Use this callus for bialaphos (10 mg / L)
Example 1 while selecting by (provided by Meiji Seika Co., Ltd.)
The cells were cultured in the same manner as in (2) to form regenerated plants. When this regenerated plant was transferred to soil for cultivation and flowering, anther dehiscence and the formation of self-fertilized seeds were observed, confirming that the plant was restored to the wild-type phenotype. From this result,
Finally, gene A was identified as the DAD1 gene.
【0039】[実施例5] 雄性不稔植物の作出(その
1、アンチセンスDAD1遺伝子を用いた方法) (1)アンチセンスDAD1遺伝子導入ベクターの構築 pGDAD1-HS を SpeI で切断し、切り出した 3651 bpの D
NA断片をpBluescriptII SK+(Stratagene社)に連結し
たプラスミドpGDAD1-SSを作製した。このプラスミドを
鋳型に、ClaI部位を挿入してあるプライマーDAD-p1(5'-
GGATCGATAGTGTCCCACGTGGGTAAC-3')とBamHI部位を挿入し
てあるプライマーDAD-p2(5'-CGCGGATCCGTTGTATATAGAGAA
TGG-3')を用いてプロモーター領域をPCRによって増幅し
た。さらに、BamHI部位を挿入してある2個のプライマー
DAD-c1(5'-CGCGGATCCACACACACTTTCTCAAC-3')とDAD-c2
(5'-CGCGGATCCACAAACCCGTCTACC-3')を用いてDAD1翻訳領
域部分をPCRによって増幅した。これらの増幅した断片
をpBluescriptII SK-(Stratagene社)に挿入し、プロ
モーター配列の後ろにDAD1翻訳領域部分を逆向きに連結
したアンチセンスDAD1遺伝子を作製した。Example 5 Production of Male Sterile Plant (Part 1, Method Using Antisense DAD1 Gene) (1) Construction of Antisense DAD1 Gene Transfer Vector pGDAD1-HS was cut with SpeI and cut out 3651 bp D
Plasmid pGDAD1-SS in which the NA fragment was ligated to pBluescriptII SK + (Stratagene) was prepared. Using this plasmid as a template, primer DAD-p1 (5'-
GGATCGATAGTGTCCCACGTGGGTAAC-3 ') and primer DAD-p2 (5'-CGCGGATCCGTTGTATATAGAGAA with BamHI site inserted)
The promoter region was amplified by PCR using TGG-3 '). In addition, two primers with BamHI sites inserted
DAD-c1 (5'-CGCGGATCCACACACACTTTCTCAAC-3 ') and DAD-c2
(5'-CGCGGATCCACAAACCCGTCTACC-3 ') was used to amplify the DAD1 translation region by PCR. These amplified fragments were inserted into pBluescriptII SK- (Stratagene) to prepare an antisense DAD1 gene in which the DAD1 translation region was ligated in the reverse direction behind the promoter sequence.
【0040】次に、アンチセンスDAD1遺伝子をプラスミ
ドベクターから切り出し、バイナリベクターpGAH(Onou
chi et al. Nucleic Acids Res. 19: 6373-6378. 199
1、名古屋大学・町田泰則教授より供与)のCla IとSac
Iの部位に挿入してバイナリープラスミドpADAD1(図
5)を作製した。Next, the antisense DAD1 gene was cut out from the plasmid vector, and the binary vector pGAH (Onou
chi et al. Nucleic Acids Res. 19: 6373-6378. 199
1.Cla I and Sac, provided by Prof. Yasunori Machida, Nagoya University)
The binary plasmid pADAD1 (FIG. 5) was prepared by insertion into the site of I.
【0041】(2)シロイヌナズナの形質転換 上記のバイナリープラスミドpADAD1をAgrobacterium tu
mefacience EHA101株に導入し、減圧浸潤(vacuum infi
ltration)法によってシロイヌナズナ(Columbiaエコタ
イプ、東北大学大学院農学研究科 植物遺伝育種学研究
室)に形質転換した。減圧浸潤法によるシロイヌナズナ
への形質転換は、モデル植物の実験プロトコール(秀潤
社 pp. 109-113.)に従って行った。(2) Transformation of Arabidopsis thaliana The above binary plasmid pADAD1 was replaced with Agrobacterium tu
Introduced into the mefacience EHA101 strain and infiltrated under reduced pressure (vacuum infi
Arabidopsis (Columbia ecotype, Plant Genetic Breeding Laboratory, Graduate School of Agriculture, Tohoku University) was transformed by the ltration method. Transformation into Arabidopsis thaliana by the vacuum infiltration method was performed according to an experimental protocol of a model plant (Shujunsha pp. 109-113.).
【0042】形質転換したシロイヌナズナは、dad1同様
に開花後も葯の裂開が起こらず(図6左)、自殖種子を
形成しなかった。形質転換体のまだ開花していない蕾を
0.5mMジャスモン酸メチル水溶液に浸したところ、その
後開花した花で葯の裂開が見られ、花粉が葯の表面に露
出した(図6右)。また、この花粉を雌しべに受粉した
結果、自殖種子の形成が認められた。このことから、実
施例5−(1)に記載の遺伝子導入ベクターを導入する
ことによって、dad1突然変異体と同様の雄性不稔性を示
す形質転換植物を作出できることが明らかになった。The transformed Arabidopsis thaliana did not undergo anther dehiscence even after flowering as in dad1 (FIG. 6, left), and did not form inbred seeds. Untransformed buds of the transformant
When immersed in a 0.5 mM aqueous methyl jasmonate solution, the flowers that had flowered thereafter showed anther dehiscence, and pollen was exposed on the surface of the anther (FIG. 6, right). In addition, as a result of pollinating this pollen with pistils, formation of self-fertilized seeds was observed. From this, it was clarified that by introducing the gene transfer vector described in Example 5- (1), a transformed plant showing male sterility similar to that of the dad1 mutant can be produced.
【0043】[実施例6] 雄性不稔植物の作出(その
2,プロモーター−GUS遺伝子導入ベクターを用いた方
法) (1)プロモーター−GUS遺伝子導入ベクターの構築 pGDAD1-HSをSplIで切断し、末端をKlenow断片で平滑化
した。次にHindIIIで切断し、3512bpのDNA断片を単離し
た。このDNA断片をバイナリーベクターpBI101.2(Clont
ec社)のHindIII部位とSmaI部位の間に連結し、DAD1遺
伝子のプロモーターにGUSレポーター遺伝子を連結した
プラスミドpBIDAD1-H(図7)を作製した。Example 6 Production of Male Sterile Plant (Part 2, Method Using Promoter-GUS Gene Transfer Vector) (1) Construction of Promoter-GUS Gene Transfer Vector pGDAD1-HS was cut with SplI, Was smoothed with a Klenow fragment. Next, it was digested with HindIII and a DNA fragment of 3512 bp was isolated. This DNA fragment was converted into a binary vector pBI101.2 (Clont
ec) between the HindIII site and the SmaI site, and a plasmid pBIDAD1-H (FIG. 7) in which the GUS reporter gene was linked to the DAD1 gene promoter.
【0044】(2)シロイヌナズナの形質転換 pBIDAD1-HをAgrobacterium tumefaciens GV3101株に導
入し、実施例5−(2)と同様に、減圧浸潤(vacuum inf
iltration)法でシロイヌナズナ(WSエコタイプ、京都
大学大学院理学研究科 植物学教室)に形質転換した。
形質転換体のシロイヌナズナの大部分では、表現型の異
常は見られなかった。これらの植物から花序を取ってX-
Gluc(5-bromo-4-chloro-3-indoril-beta-D-glucuronid
e、和光純薬)溶液で染色したところ、花糸に強い染色
が観察された。一方、一部の形質転換体では、開花後も
葯の裂開が起こらないというdad1突然変異体と同様の表
現型が観察された。ジャスモン酸処理による裂開能の回
復も観察された。これらの個体では、X-Glucによる染色
も弱くなる傾向が見られた。(2) Transformation of Arabidopsis thaliana pBIDAD1-H was introduced into Agrobacterium tumefaciens strain GV3101, and the cells were infiltrated under reduced pressure (vacuum inf) as in Example 5- (2).
Arabidopsis (WS ecotype, Kyoto University Graduate School of Science, Department of Botany) was transformed by the iltration method.
In most of the transformants, Arabidopsis thaliana showed no phenotypic abnormality. Take inflorescences from these plants and X-
Gluc (5-bromo-4-chloro-3-indoril-beta-D-glucuronid
e, Wako Pure Chemical Industries) solution, strong staining was observed in the thread. On the other hand, in some of the transformants, a phenotype similar to that of the dad1 mutant was observed, in which the anther did not cleave even after flowering. Restoration of cleavage ability by jasmonic acid treatment was also observed. In these individuals, the staining with X-Gluc also tended to be weak.
【0045】[実施例7]DAD1遺伝子プローブを用いた
サザンハイブリダイゼーション(図8) シロイヌナズナ以外の植物種のゲノムDNA中にもDAD1遺
伝子と類似の遺伝子が存在するのかを調査するために、
アブラナ科、イネ科、キク科、アカザ科植物のゲノムDN
Aを用いてサザン分析を行った。コマツナ品種おそめ
(タキイ種苗(株))、ブロッコリー品種グリーンコメ
ット(タキイ種苗(株))、イネ(ヤマホウシ、ササニ
シキ)、オオムギ(大六角一号)、トウモロコシ(スイ
ートム102、(株)藤井農産)、レタス2品種(Vレタ
ス(カネコ(株)、およびサマーレッド(タキイ種苗
(株)))、並びにサトウダイコン(北海道大学農学部
より供与)の葉からCTAB法(Murray and Thompson Nucl
eic. Acids Res. 8:4321-4325,1980)によりゲノムDNA
を抽出した。ゲノムDNAを制限酵素EcoRIで消化し、0.7%
アガロースゲルに電気泳動した。メンブランにDNAを写
し取り、DAD1遺伝子をプローブに用いてハイブリダイゼ
ーションを行った後、0.5x SSC, 0.1% SDS, 65℃の条件
で洗いを行った。この結果、供試した全ての植物に本遺
伝子あるいはそれと配列が近似している遺伝子の存在が
確認された。Example 7 Southern Hybridization Using DAD1 Gene Probe (FIG. 8) In order to investigate whether a gene similar to the DAD1 gene is present in genomic DNA of plant species other than Arabidopsis thaliana,
Genome DN of Brassicaceae, Gramineae, Compositae, and Brassicaceae
Southern analysis was performed using A. Komatsuna varieties Osome (Takii Seed Co., Ltd.), broccoli varieties Green Comet (Takii Seed Co., Ltd.), rice (Yamahoushi, Sasanishiki), barley (Daikoku No. 1), corn (Sweetome 102, Fujii Nosan) , Lettuce varieties (V lettuce (Kaneko Co., Ltd. and Summer Red (Takii Seedling Co., Ltd.))) and sugar beet (provided by Hokkaido University Faculty of Agriculture) CTAB method (Murray and Thompson Nucl
eic. Acids Res. 8: 4321-4325,1980)
Was extracted. Genomic DNA is digested with restriction enzyme EcoRI, 0.7%
Electrophoresed on agarose gel. The DNA was transferred to a membrane, hybridized using the DAD1 gene as a probe, and then washed under conditions of 0.5 × SSC, 0.1% SDS and 65 ° C. As a result, it was confirmed that the present gene or a gene whose sequence is similar to the present gene was present in all the plants tested.
【0046】[0046]
【発明の効果】本発明は、植物の葯の裂開を制御する核
遺伝子及びその遺伝子の発現が抑制されている雄性不稔
植物を提供する。この雄性不稔植物は、その花器官が野
生型に限りなく近く、また、ジャスモン酸等により稔性
を回復させることのできるため、F1種子生産のために極
めて有用である。Industrial Applicability The present invention provides a nuclear gene that controls the dehiscence of anthers of a plant and a male sterile plant in which expression of the gene is suppressed. This male sterile plant is extremely useful for F1 seed production because its flower organs are as close as possible to the wild type and its fertility can be restored with jasmonic acid or the like.
【0047】[0047]
【配列表】 SEQUENCE LISTING <110> Research Institute of Seed Production Co., Ltd. <120> YAKU NO REKKAI NI KANYOSURU IDENSHI <130> P99-0082 <160> 3 <170> PatentIn Ver. 2.0 <210> 1 <211> 8133 <212> DNA <213> Arabidopsis thaliana <220> <221> CDS <222> (3487)..(4827) <400> 1 aagcttcttt attacccaat taagtaaata tcccaaacaa ttccattttg catgtaaact 60 taatgtcact attccctaaa ttaaattaca caaaattgca gtgtatgtta tgatgattgt 120 ttgatacttt attccctcct agatattatc ttaaagatca acctttgtgt tgagtaattt 180 cgttgtatag gcttgtggaa tatatacttc aattcttatc agaccataga gtcagatcat 240 ttccacgaat ccttatagaa acatttagtt atgaaataaa acacatccga aataactagc 300 tattagatat aagaaaaaat ttaaaaatat tattgctcat cacagatttt ggaaaaatat 360 atattcatct aatcatgtta atagtcgcca tatatatacg cacattattg ttaaattgaa 420 caatctttgt aaaattatgt ttgttttgaa tattcttata aacatagaga aaattgcata 480 ttatctgttt gtaatgaaac gtatatttat tatatataga ccgatataca ataaagtagc 540 tagtaatagt attgaacaac aattgatcac caaaagaaag ttgttagctg gcttctgatg 600 gtttaacggc tcagttatga cttattcgag ctgcaccaga tactgttagc ttgctttagt 660 cgactttttt ttttttttaa caaacaaatg aaaatagtcg ttaagaagga cttcattgtt 720 agctactaac atacattcat tcatttgggt tatattatgc atgtagaaaa ctcatatgat 780 aaaatgtgcc gaatcgagcc taacaaacag gggacatggc agtaaatata gttataaatt 840 ttcttacacc ctattacaga gaaaggtgaa ttttgttttt tttgtcacag tgaaatttgt 900 ttatatattg aaatatttat acatgcataa actataaact atagttataa gtgtaattgt 960 ctctctttgc cctttttctt tatttcaaga atggtagctt aagtatataa gttttacttg 1020 taaataagtt ttggtagtat atagaagaat ccgagtagaa aactcatact aagtactata 1080 gagcatgaga aataagaaat tcataatgta gtttatcgta tgagttgact ggatgataga 1140 taccataaat atattaagtt aaaagattct actaaacgaa gaccaactgc aaagctacgt 1200 atatatttat ccactgcgta aactaaactt tttctctaca tcgatctctc aatctttggt 1260 cggttcactt tacaaatcat aaatatataa gagtcggttt agttctttac aaaaaatcaa 1320 catcgatcaa agttgatgtc atggctatca ctccattctt ctctgttggc ctcctttaaa 1380 atttacctct taattttctt ttggtatgga aagaagaaat actctttaat gttttccgta 1440 acaacgtgga caaatggtcc cgaaagaaga aatggccaat gtaaatgata ttgaaatagt 1500 cccatcggaa aaaagagtga agaaattaaa cattataaag aaccaattaa tggcttttgt 1560 ggtgtgtagt attgtgtcca caaatatatg aatggtcacg ttggtttgat atatccaaaa 1620 cgatgacatt taaatcgggg aatgtaagta aagtacgtgt cataaccaat agttctaaag 1680 tggtgcatgc aatttttgtt tattacaaaa caagaaattt gttcccaatc gattggaaca 1740 ccaaatcact ttaattgctt aagcactttg atcgtattcc taacgaagac attttccacg 1800 cgttccatgt gcatctcctc ctcagtatct atggtttatc gtgtaaatta aaactccttt 1860 cttcaagtta gttcatagtc tacataattc tttttactgc atataacata taatattctg 1920 taagatatca agaatctaaa agtgttttta ttactagtgt cccacgtggg taacatttga 1980 aatgcattca aacgatgtga taatgtgaaa tgcttaaaag tatatagagt taaaacagtc 2040 tttcagaaat cacgatggtt atcaatacaa tataaagaaa atattgcaaa acagctaaga 2100 ctctaatagg atttataaat gaaaagaggc tatatgttat taaaaagcac aagactaata 2160 tataaagagc tacgacatgt gatgtgaaat tcaaatagta agtaactcac gttgcacttc 2220 ttttattcgt cgttttgccc gaacaacaca tcactccaac ttatttaatt ggacttattc 2280 tgttacccgc gatataggct agcaagataa atttcatcgc gacatttcat atcttgatca 2340 ttctgcctta ttcaatggat tcattcaacc attctctgct catttggata tgatcattta 2400 cacttacatt ttatatttag attctaagtc gataactaat tttaagattg ttatatgttg 2460 cttttatacg tagacataaa acttgtcgtt aattgtataa aaacaatatg ctagaagcct 2520 agaagggcgt gggaatatag gaggtgtata cttcgtactt tccttgagca ttcaaattca 2580 gcaattggcg gcgaatggct aaagccgaaa gtaccaaatc cagccgatat gagccgagtc 2640 gagctggtga tagttcctca cgtgtcaaag cctttctgag ccgtattgtt tgagaactcc 2700 cacgtgtcca gtcccatcga aaacgacggt cagatattta tttcgataca cacttctttc 2760 tcttctcata tcatctcagc cgtccatttc tcttagtctc attatcatac atttacttct 2820 tctttttttt tttggtcacc aattcggtta aatccttttt tttttgtaaa tataagtcac 2880 attaaaaaag agagtaaaaa cgtgatgtca aaaacacaac taataacgta gaatccattc 2940 atgatcccaa atattgattt cacattgtct ttatggtcca tgttagttaa gtaaaagaaa 3000 gaaagagcaa acatagctta tgtgtaccac ataatcattt atatagtatt gaaactttgt 3060 caaagattgt actcattctt catagaataa aatatacaaa cccagctatt gttagctttc 3120 taatttggta catttattgc ttttacatac acgaaaacta cttgaaatcc tacatacaca 3180 aacgagtacc aatgtgtgta tttgggtatt agatataaat tcatatactt atataagcac 3240 tgtccacaat tttcagagtc gagtcctttc attttcaaca atctctttaa ctccactata 3300 gatcccaact tttctcacta taaaaggaac ccatttcctc tttccttcaa tcactttatc 3360 ttcttacacc aaatctatct tcaagacttc aacatactcc attctctata tacaaccttt 3420 ttaagaaaac tttgattaat cagatcaaat atttataaat taaaacacac acacactttc 3480 tcaaca atg aga ttc tct ctt tct ccc gta cgt ccg cat agt gta gta 3528 Met Arg Phe Ser Leu Ser Pro Val Arg Pro His Ser Val Val 1 5 10 gta cct tca cta cca aaa cag gac gtc gtt tct tat ata agt ggt acg 3576 Val Pro Ser Leu Pro Lys Gln Asp Val Val Ser Tyr Ile Ser Gly Thr 15 20 25 30 acg tcg aat cgt caa tgt cga tgt gta ctt aca ctt cct tct cct tca 3624 Thr Ser Asn Arg Gln Cys Arg Cys Val Leu Thr Leu Pro Ser Pro Ser 35 40 45 gtt tcc act tcc cga cca ccg gtt tta ccc aaa ccg gaa acc tgg gag 3672 Val Ser Thr Ser Arg Pro Pro Val Leu Pro Lys Pro Glu Thr Trp Glu 50 55 60 agt ttg ctg cta aac cat gat caa att cca ggc gaa ttc tca ccc act 3720 Ser Leu Leu Leu Asn His Asp Gln Ile Pro Gly Glu Phe Ser Pro Thr 65 70 75 ggt tcg agt atc ccg gtt aag ctt ggc cgg aga tgg atg gag tat cag 3768 Gly Ser Ser Ile Pro Val Lys Leu Gly Arg Arg Trp Met Glu Tyr Gln 80 85 90 ggg ctt caa aat tgg gac ggt ctt tta gac cca ttg gac gac aat ctc 3816 Gly Leu Gln Asn Trp Asp Gly Leu Leu Asp Pro Leu Asp Asp Asn Leu 95 100 105 110 cgg cga gag att ctc cgg tac ggt caa ttt gtc gaa tcg gct tat caa 3864 Arg Arg Glu Ile Leu Arg Tyr Gly Gln Phe Val Glu Ser Ala Tyr Gln 115 120 125 gca ttt gat ttc gat cct tcc tct cca acc tac ggg aca tgc cgg ttt 3912 Ala Phe Asp Phe Asp Pro Ser Ser Pro Thr Tyr Gly Thr Cys Arg Phe 130 135 140 ccg agg agc acg ttg tta gag cga tcc ggt tta ccc aac tcc ggt tat 3960 Pro Arg Ser Thr Leu Leu Glu Arg Ser Gly Leu Pro Asn Ser Gly Tyr 145 150 155 cga cta acg aag aac ctt cgt gcc acg tca ggt att aac ttg cca cgt 4008 Arg Leu Thr Lys Asn Leu Arg Ala Thr Ser Gly Ile Asn Leu Pro Arg 160 165 170 tgg att gag aaa gcg cca agc tgg atg gct aca caa tct agc tgg att 4056 Trp Ile Glu Lys Ala Pro Ser Trp Met Ala Thr Gln Ser Ser Trp Ile 175 180 185 190 ggt tac gtg gca gtt tgc cag gac aaa gaa gag atc tcg cgg ctt ggg 4104 Gly Tyr Val Ala Val Cys Gln Asp Lys Glu Glu Ile Ser Arg Leu Gly 195 200 205 cgt aga gac gtc gtc atc tcc ttc cgt gga acc gcc acg tgt ctc gag 4152 Arg Arg Asp Val Val Ile Ser Phe Arg Gly Thr Ala Thr Cys Leu Glu 210 215 220 tgg tta gag aac ctt cgc gcc acg ctg act cat ctc cct aat ggg cct 4200 Trp Leu Glu Asn Leu Arg Ala Thr Leu Thr His Leu Pro Asn Gly Pro 225 230 235 act gga gca aat cta aac ggg tct aac tct ggg ccc atg gtt gag agc 4248 Thr Gly Ala Asn Leu Asn Gly Ser Asn Ser Gly Pro Met Val Glu Ser 240 245 250 ggg ttt tta agc ttg tat act tca ggt gtt cac agt ttg aga gac atg 4296 Gly Phe Leu Ser Leu Tyr Thr Ser Gly Val His Ser Leu Arg Asp Met 255 260 265 270 gta aga gaa gag atc gca agg cta ctc caa tct tac ggc gac gag ccg 4344 Val Arg Glu Glu Ile Ala Arg Leu Leu Gln Ser Tyr Gly Asp Glu Pro 275 280 285 tta agt gta acg ata acc ggt cac agc ctc ggc gct gcg atc gcg aca 4392 Leu Ser Val Thr Ile Thr Gly His Ser Leu Gly Ala Ala Ile Ala Thr 290 295 300 cta gca gct tac gat atc aaa acg acg ttt aaa cgt gcg cct atg gtt 4440 Leu Ala Ala Tyr Asp Ile Lys Thr Thr Phe Lys Arg Ala Pro Met Val 305 310 315 acc gta ata tct ttc gga ggt cca cgt gtc gga aac aga tgc ttt cgg 4488 Thr Val Ile Ser Phe Gly Gly Pro Arg Val Gly Asn Arg Cys Phe Arg 320 325 330 aaa ctc ctt gag aag caa ggc acg aag gtt cta aga atc gtg aac tcc 4536 Lys Leu Leu Glu Lys Gln Gly Thr Lys Val Leu Arg Ile Val Asn Ser 335 340 345 350 gac gac gtc atc acc aaa gtt cct gga gtt gtt tta gaa aac aga gag 4584 Asp Asp Val Ile Thr Lys Val Pro Gly Val Val Leu Glu Asn Arg Glu 355 360 365 caa gat aac gtt aag atg aca gcg tcg ata atg ccg agc tgg ata cag 4632 Gln Asp Asn Val Lys Met Thr Ala Ser Ile Met Pro Ser Trp Ile Gln 370 375 380 aga cgc gtg gag gag acg ccg tgg gtt tac gct gaa atc ggt aag gag 4680 Arg Arg Val Glu Glu Thr Pro Trp Val Tyr Ala Glu Ile Gly Lys Glu 385 390 395 ctt cgg ctg agt agc cgt gac tcg ccg cac ttg agc agc atc aat gtg 4728 Leu Arg Leu Ser Ser Arg Asp Ser Pro His Leu Ser Ser Ile Asn Val 400 405 410 gcc acg tgt cat gag ctg aaa acg tat tta cat ttg gta gac ggg ttt 4776 Ala Thr Cys His Glu Leu Lys Thr Tyr Leu His Leu Val Asp Gly Phe 415 420 425 430 gtg agc tcc acg tgt cca ttc aga gaa aca gct cgg aga gtt ctc cat 4824 Val Ser Ser Thr Cys Pro Phe Arg Glu Thr Ala Arg Arg Val Leu His 435 440 445 aga tgaagattca ttgatccgac attcgtaact aatttaattt tgtgcaaaga 4877 Arg aacactaaac cgggaagaaa atcaagaacc gcgtaacggt ttgattcggt taacaaatca 4937 atttcgtgac atatctctaa cttagcggta gaattagaaa agaaagtaaa gtagaagaca 4997 gctctaaagg gcgaaaaatg aaaaatgtat tgaagctcgt ataatctcaa attgtttata 5057 tactgtatag tgtttttaaa aaaaattgcc ggtaattatg aaaatgtggt cataaatcat 5117 aaaattttgt cgcacgagca tgtgctacta aaactcctaa aggcgtaaat tgtcttaact 5177 tggacagaaa aggaagtgaa aagacaaaaa tgtccctatc tccgtccaaa tatgagaaat 5237 gggaatgccc caatgatggt gccacgtaag caccgaccgt tcgaagaagt tgactggatc 5297 tctgtacttg gcaaaaaagc ttaaaagatt cagttgcttg caaaatctga atgcccaatg 5357 agaacacgca tcatgcgccg tccatttatt taccgtatag tatttacttt cctcgttacc 5417 aggaaaattc accatcaacg cgttattttg tgggtgtgtc atgtctgtgt tgttttaaaa 5477 ctctccataa aagttggttt tatgttaacg tactactaag aaagaccata aaataatggc 5537 caagaaatgg gatatatgat tctcgtgata atgcgttatt ctatgagtaa tataaagcaa 5597 actagtgttc agttccatgt gtattaatat aaaagtatca tgttgtataa gtaaatagaa 5657 tatttcaaaa taattataat atttctatat gtatgctaaa cataattaca tggttcattg 5717 gcgtagagaa aataacattt tatcatgttt tgtatatatc ttaatgcata acacattctc 5777 acttagaact atctattatc tatttatttt tattttataa tattgtgttt ttcatttaat 5837 ataaaaaatt cagacaatga tatatactca aaataatctt tcaaaaacac ataaaattat 5897 catcgaacag gaagggtaaa taatagaaga tcttttttgt ttgtgtgtgg gttaaatata 5957 tgacggactc taagcatatg attatgtagt cattgaaatt agatatagtt ttcaattttt 6017 catatagtcg ttccttcttt tctcaaaaag aaaccactta actgagaagt gcacgaaaac 6077 ggtcagcatc actgtttttg cggtgacttg aaagggagaa tatatcgcat gcaaagatcc 6137 aagccgtata cgtacatata caggcacgtc gtagtctcaa atatatatgc acaaaagtga 6197 atagatcgca taccgaccca tacctaaaat gctagctttg aagctataca tagctttaga 6257 aagtgaccat catcgtcatc gttacttgtt actttgttag acccacacca ttcctcgtcc 6317 aaaaatctat caaatatgga gaccgccaca tattttagat tattaagctt atattgaagg 6377 gttttatatt tctttcttgc gtacatttct ctttcgtttt ctctaatgat ttaagttaga 6437 ttagagaggt caataacgta tgcagttaac cttttccatt tcccgttatt gtggaaacct 6497 cagtttgact acatactccg accacttttt agtgatattt aacacaaaaa gaacttttga 6557 aaaactaatt tatcggtgtg actttttttg ttcgcttgtg catttttttc caacactggt 6617 ccataagttt accatgtaac atatattagt atttagagtt agtatatttc tacaaatatg 6677 tgcacagcta gctagcatta cttggaccct taaaggtgac atgtattgga tataggaaat 6737 caggacccct ttagcaaaaa aaaaaaaaag aaaaaaaaaa gaaaatcagg accatcttaa 6797 aactatttgt tcctctctat ataatggttt ataatcataa ttaagattta aagtacaaat 6857 tatagttatt aaaaaggtta gttctcacag ataataacag aaaatatttt aagttaccaa 6917 ttttagcaca taatatctaa agtttttaaa atactatgaa tttaatatca aaaatcttat 6977 ataagtattt gatggacgct ttacgcgata ataatagaat catgatttca aattgtgatt 7037 aattttttac gtaattcggt gaagataagt aattcttgta taaatttcac taatgttaat 7097 tttaaaagtt tatggaagat atgatataat tgttcataaa acttgttata atgctattat 7157 aagatatttt tcttaaaaag acaagtaaat tactttgttc gtcgaacaca aactaactta 7217 cgcttgatca agctgtattc tacaaaagtt atacattatt aatttatcat tacaaaaatt 7277 ggaaaaaggt tactttaaca attcaaaaat atatcgaaat ccaaaaagat ttatcaactc 7337 cttttaaatt tcacgtttta cgtgaatcat gtgatataat catatgcata caaatgtcat 7397 ctgagagatt tcagccgact tttgaacaag gaccaaaaca gcctacgcca tgcggagacc 7457 acgaaaatag atattttatt ataaataaat ggattttttt ggacgtaatg aaacgagaag 7517 tggatcagaa gattaattac ataatctttt ctatttataa atttaaacta tttctttcta 7577 attcattaac aattttgata catcaggaca atggtaactt atgttactat aagacaatgg 7637 taatatctca atagaagttt ttttttgtaa aatcgcaata tatacatgaa ttaataatga 7697 catatgatgg tcatttggac ataatataaa aatataaata tttggcaaaa taaataagta 7757 aatgaagggg agaggaatgt gtgagtgtgt gtgggtgtgg atgcctttat gcctcctaca 7817 tctcaacatt gagcaaaatt gcggctgccc aacaaccacc caaaagagaa ttagtcaaaa 7877 ttattaaaat caatgcatgt cctaatctct ctcacccaac tctcaccttc atttcaactc 7937 ccatgcatct ttttggtcaa ttaatttatt aatattataa atatattttt tcaatgaatt 7997 ttgaaaagac tgtgttgcat attaaaataa tgcgttgtac tattaagagt caaattagaa 8057 aatgtacttt taactccaaa ttaatttaca acatcttaga ttatgttatt tttttttttt 8117 caagtcttca cgtacg 8133 <210> 2 <211> 447 <212> PRT <213> Arabidopsis thaliana <400> 2 Met Arg Phe Ser Leu Ser Pro Val Arg Pro His Ser Val Val Val Pro 1 5 10 15 Ser Leu Pro Lys Gln Asp Val Val Ser Tyr Ile Ser Gly Thr Thr Ser 20 25 30 Asn Arg Gln Cys Arg Cys Val Leu Thr Leu Pro Ser Pro Ser Val Ser 35 40 45 Thr Ser Arg Pro Pro Val Leu Pro Lys Pro Glu Thr Trp Glu Ser Leu 50 55 60 Leu Leu Asn His Asp Gln Ile Pro Gly Glu Phe Ser Pro Thr Gly Ser 65 70 75 80 Ser Ile Pro Val Lys Leu Gly Arg Arg Trp Met Glu Tyr Gln Gly Leu 85 90 95 Gln Asn Trp Asp Gly Leu Leu Asp Pro Leu Asp Asp Asn Leu Arg Arg 100 105 110 Glu Ile Leu Arg Tyr Gly Gln Phe Val Glu Ser Ala Tyr Gln Ala Phe 115 120 125 Asp Phe Asp Pro Ser Ser Pro Thr Tyr Gly Thr Cys Arg Phe Pro Arg 130 135 140 Ser Thr Leu Leu Glu Arg Ser Gly Leu Pro Asn Ser Gly Tyr Arg Leu 145 150 155 160 Thr Lys Asn Leu Arg Ala Thr Ser Gly Ile Asn Leu Pro Arg Trp Ile 165 170 175 Glu Lys Ala Pro Ser Trp Met Ala Thr Gln Ser Ser Trp Ile Gly Tyr 180 185 190 Val Ala Val Cys Gln Asp Lys Glu Glu Ile Ser Arg Leu Gly Arg Arg 195 200 205 Asp Val Val Ile Ser Phe Arg Gly Thr Ala Thr Cys Leu Glu Trp Leu 210 215 220 Glu Asn Leu Arg Ala Thr Leu Thr His Leu Pro Asn Gly Pro Thr Gly 225 230 235 240 Ala Asn Leu Asn Gly Ser Asn Ser Gly Pro Met Val Glu Ser Gly Phe 245 250 255 Leu Ser Leu Tyr Thr Ser Gly Val His Ser Leu Arg Asp Met Val Arg 260 265 270 Glu Glu Ile Ala Arg Leu Leu Gln Ser Tyr Gly Asp Glu Pro Leu Ser 275 280 285 Val Thr Ile Thr Gly His Ser Leu Gly Ala Ala Ile Ala Thr Leu Ala 290 295 300 Ala Tyr Asp Ile Lys Thr Thr Phe Lys Arg Ala Pro Met Val Thr Val 305 310 315 320 Ile Ser Phe Gly Gly Pro Arg Val Gly Asn Arg Cys Phe Arg Lys Leu 325 330 335 Leu Glu Lys Gln Gly Thr Lys Val Leu Arg Ile Val Asn Ser Asp Asp 340 345 350 Val Ile Thr Lys Val Pro Gly Val Val Leu Glu Asn Arg Glu Gln Asp 355 360 365 Asn Val Lys Met Thr Ala Ser Ile Met Pro Ser Trp Ile Gln Arg Arg 370 375 380 Val Glu Glu Thr Pro Trp Val Tyr Ala Glu Ile Gly Lys Glu Leu Arg 385 390 395 400 Leu Ser Ser Arg Asp Ser Pro His Leu Ser Ser Ile Asn Val Ala Thr 405 410 415 Cys His Glu Leu Lys Thr Tyr Leu His Leu Val Asp Gly Phe Val Ser 420 425 430 Ser Thr Cys Pro Phe Arg Glu Thr Ala Arg Arg Val Leu His Arg 435 440 445 <210> 3 <211> 3422 <212> DNA <213> Arabidopsis thaliana <220> <221> promoter <222> (1)..(3422) <400> 3 aagcttcttt attacccaat taagtaaata tcccaaacaa ttccattttg catgtaaact 60 taatgtcact attccctaaa ttaaattaca caaaattgca gtgtatgtta tgatgattgt 120 ttgatacttt attccctcct agatattatc ttaaagatca acctttgtgt tgagtaattt 180 cgttgtatag gcttgtggaa tatatacttc aattcttatc agaccataga gtcagatcat 240 ttccacgaat ccttatagaa acatttagtt atgaaataaa acacatccga aataactagc 300 tattagatat aagaaaaaat ttaaaaatat tattgctcat cacagatttt ggaaaaatat 360 atattcatct aatcatgtta atagtcgcca tatatatacg cacattattg ttaaattgaa 420 caatctttgt aaaattatgt ttgttttgaa tattcttata aacatagaga aaattgcata 480 ttatctgttt gtaatgaaac gtatatttat tatatataga ccgatataca ataaagtagc 540 tagtaatagt attgaacaac aattgatcac caaaagaaag ttgttagctg gcttctgatg 600 gtttaacggc tcagttatga cttattcgag ctgcaccaga tactgttagc ttgctttagt 660 cgactttttt ttttttttaa caaacaaatg aaaatagtcg ttaagaagga cttcattgtt 720 agctactaac atacattcat tcatttgggt tatattatgc atgtagaaaa ctcatatgat 780 aaaatgtgcc gaatcgagcc taacaaacag gggacatggc agtaaatata gttataaatt 840 ttcttacacc ctattacaga gaaaggtgaa ttttgttttt tttgtcacag tgaaatttgt 900 ttatatattg aaatatttat acatgcataa actataaact atagttataa gtgtaattgt 960 ctctctttgc cctttttctt tatttcaaga atggtagctt aagtatataa gttttacttg 1020 taaataagtt ttggtagtat atagaagaat ccgagtagaa aactcatact aagtactata 1080 gagcatgaga aataagaaat tcataatgta gtttatcgta tgagttgact ggatgataga 1140 taccataaat atattaagtt aaaagattct actaaacgaa gaccaactgc aaagctacgt 1200 atatatttat ccactgcgta aactaaactt tttctctaca tcgatctctc aatctttggt 1260 cggttcactt tacaaatcat aaatatataa gagtcggttt agttctttac aaaaaatcaa 1320 catcgatcaa agttgatgtc atggctatca ctccattctt ctctgttggc ctcctttaaa 1380 atttacctct taattttctt ttggtatgga aagaagaaat actctttaat gttttccgta 1440 acaacgtgga caaatggtcc cgaaagaaga aatggccaat gtaaatgata ttgaaatagt 1500 cccatcggaa aaaagagtga agaaattaaa cattataaag aaccaattaa tggcttttgt 1560 ggtgtgtagt attgtgtcca caaatatatg aatggtcacg ttggtttgat atatccaaaa 1620 cgatgacatt taaatcgggg aatgtaagta aagtacgtgt cataaccaat agttctaaag 1680 tggtgcatgc aatttttgtt tattacaaaa caagaaattt gttcccaatc gattggaaca 1740 ccaaatcact ttaattgctt aagcactttg atcgtattcc taacgaagac attttccacg 1800 cgttccatgt gcatctcctc ctcagtatct atggtttatc gtgtaaatta aaactccttt 1860 cttcaagtta gttcatagtc tacataattc tttttactgc atataacata taatattctg 1920 taagatatca agaatctaaa agtgttttta ttactagtgt cccacgtggg taacatttga 1980 aatgcattca aacgatgtga taatgtgaaa tgcttaaaag tatatagagt taaaacagtc 2040 tttcagaaat cacgatggtt atcaatacaa tataaagaaa atattgcaaa acagctaaga 2100 ctctaatagg atttataaat gaaaagaggc tatatgttat taaaaagcac aagactaata 2160 tataaagagc tacgacatgt gatgtgaaat tcaaatagta agtaactcac gttgcacttc 2220 ttttattcgt cgttttgccc gaacaacaca tcactccaac ttatttaatt ggacttattc 2280 tgttacccgc gatataggct agcaagataa atttcatcgc gacatttcat atcttgatca 2340 ttctgcctta ttcaatggat tcattcaacc attctctgct catttggata tgatcattta 2400 cacttacatt ttatatttag attctaagtc gataactaat tttaagattg ttatatgttg 2460 cttttatacg tagacataaa acttgtcgtt aattgtataa aaacaatatg ctagaagcct 2520 agaagggcgt gggaatatag gaggtgtata cttcgtactt tccttgagca ttcaaattca 2580 gcaattggcg gcgaatggct aaagccgaaa gtaccaaatc cagccgatat gagccgagtc 2640 gagctggtga tagttcctca cgtgtcaaag cctttctgag ccgtattgtt tgagaactcc 2700 cacgtgtcca gtcccatcga aaacgacggt cagatattta tttcgataca cacttctttc 2760 tcttctcata tcatctcagc cgtccatttc tcttagtctc attatcatac atttacttct 2820 tctttttttt tttggtcacc aattcggtta aatccttttt tttttgtaaa tataagtcac 2880 attaaaaaag agagtaaaaa cgtgatgtca aaaacacaac taataacgta gaatccattc 2940 atgatcccaa atattgattt cacattgtct ttatggtcca tgttagttaa gtaaaagaaa 3000 gaaagagcaa acatagctta tgtgtaccac ataatcattt atatagtatt gaaactttgt 3060 caaagattgt actcattctt catagaataa aatatacaaa cccagctatt gttagctttc 3120 taatttggta catttattgc ttttacatac acgaaaacta cttgaaatcc tacatacaca 3180 aacgagtacc aatgtgtgta tttgggtatt agatataaat tcatatactt atataagcac 3240 tgtccacaat tttcagagtc gagtcctttc attttcaaca atctctttaa ctccactata 3300 gatcccaact tttctcacta taaaaggaac ccatttcctc tttccttcaa tcactttatc 3360 ttcttacacc aaatctatct tcaagacttc aacatactcc attctctata tacaaccttt 3420 tt 3422[Sequence List] SEQUENCE LISTING <110> Research Institute of Seed Production Co., Ltd. <120> YAKU NO REKKAI NI KANYOSURU IDENSHI <130> P99-0082 <160> 3 <170> PatentIn Ver. 2.0 <210> 1 < 211> 8133 <212> DNA <213> Arabidopsis thaliana <220> <221> CDS <222> (3487) .. (4827) <400> agatattatc ttaaagatca acctttgtgt tgagtaattt 180 cgttgtatag gcttgtggaa tatatacttc aattcttatc agaccataga gtcagatcat 240 ttccacgaat ccttatagaa acatttagtt atgaaataaa acacatccga aataactagc 300 tattagatat aagaaaaaat ttaaaaatat tattgctcat cacagatttt ggaaaaatat 360 atattcatct aatcatgtta atagtcgcca tatatatacg cacattattg ttaaattgaa 420 caatctttgt aaaattatgt ttgttttgaa tattcttata aacatagaga aaattgcata 480 ttatctgttt gtaatgaaac gtatatttat tatatataga ccgatataca ataaagtagc 540 tagtaatagt attgaacaac aattgatcac caaaagaaag ttgttagctg gcttctgatg 600 gtttaacggc tcagttatga ct tattcgag ctgcaccaga tactgttagc ttgctttagt 660 cgactttttt ttttttttaa caaacaaatg aaaatagtcg ttaagaagga cttcattgtt 720 agctactaac atacattcat tcatttgggt tatattatgc atgtagaaaa ctcatatgat 780 aaaatgtgcc gaatcgagcc taacaaacag gggacatggc agtaaatata gttataaatt 840 ttcttacacc ctattacaga gaaaggtgaa ttttgttttt tttgtcacag tgaaatttgt 900 ttatatattg aaatatttat acatgcataa actataaact atagttataa gtgtaattgt 960 ctctctttgc cctttttctt tatttcaaga atggtagctt aagtatataa gttttacttg 1020 taaataagtt ttggtagtat atagaagaat ccgagtagaa aactcatact aagtactata 1080 gagcatgaga aataagaaat tcataatgta gtttatcgta tgagttgact ggatgataga 1140 taccataaat atattaagtt aaaagattct actaaacgaa gaccaactgc aaagctacgt 1200 atatatttat ccactgcgta aactaaactt tttctctaca tcgatctctc aatctttggt 1260 cggttcactt tacaaatcat aaatatataa gagtcggttt agttctttac aaaaaatcaa 1320 catcgatcaa agttgatgtc atggctatca ctccattctt ctctgttggc ctcctttaaa 1380 atttacctct taattttctt ttggtatgga aagaagaaat actctttaat gttttccgta 1440 acaacgtgga caaatggtcc cgaaagaaga aat ggccaat gtaaatgata ttgaaatagt 1500 cccatcggaa aaaagagtga agaaattaaa cattataaag aaccaattaa tggcttttgt 1560 ggtgtgtagt attgtgtcca caaatatatg aatggtcacg ttggtttgat atatccaaaa 1620 cgatgacatt taaatcgggg aatgtaagta aagtacgtgt cataaccaat agttctaaag 1680 tggtgcatgc aatttttgtt tattacaaaa caagaaattt gttcccaatc gattggaaca 1740 ccaaatcact ttaattgctt aagcactttg atcgtattcc taacgaagac attttccacg 1800 cgttccatgt gcatctcctc ctcagtatct atggtttatc gtgtaaatta aaactccttt 1860 cttcaagtta gttcatagtc tacataattc tttttactgc atataacata taatattctg 1920 taagatatca agaatctaaa agtgttttta ttactagtgt cccacgtggg taacatttga 1980 aatgcattca aacgatgtga taatgtgaaa tgcttaaaag tatatagagt taaaacagtc 2040 tttcagaaat cacgatggtt atcaatacaa tataaagaaa atattgcaaa acagctaaga 2100 ctctaatagg atttataaat gaaaagaggc tatatgttat taaaaagcac aagactaata 2160 tataaagagc tacgacatgt gatgtgaaat tcaaatagta agtaactcac gttgcacttc 2220 ttttattcgt cgttttgccc gaacaacaca tcactccaac ttatttaatt ggacttattc 2280 tgttacccgc gatataggct agcaagataa atttcatcg c gacatttcat atcttgatca 2340 ttctgcctta ttcaatggat tcattcaacc attctctgct catttggata tgatcattta 2400 cacttacatt ttatatttag attctaagtc gataactaat tttaagattg ttatatgttg 2460 cttttatacg tagacataaa acttgtcgtt aattgtataa aaacaatatg ctagaagcct 2520 agaagggcgt gggaatatag gaggtgtata cttcgtactt tccttgagca ttcaaattca 2580 gcaattggcg gcgaatggct aaagccgaaa gtaccaaatc cagccgatat gagccgagtc 2640 gagctggtga tagttcctca cgtgtcaaag cctttctgag ccgtattgtt tgagaactcc 2700 cacgtgtcca gtcccatcga aaacgacggt cagatattta tttcgataca cacttctttc 2760 tcttctcata tcatctcagc cgtccatttc tcttagtctc attatcatac atttacttct 2820 tctttttttt tttggtcacc aattcggtta aatccttttt tttttgtaaa tataagtcac 2880 attaaaaaag agagtaaaaa cgtgatgtca aaaacacaac taataacgta gaatccattc 2940 atgatcccaa atattgattt cacattgtct ttatggtcca tgttagttaa gtaaaagaaa 3000 gaaagagcaa acatagctta tgtgtaccac ataatcattt atatagtatt gaaactttgt 3060 caaagattgt actcattctt catagaataa aatatacaaa cccagctatt gttagctttc 3120 taatttggta catttattgc ttttacatac acgaaaacta cttg aaatcc tacatacaca 3180 aacgagtacc aatgtgtgta tttgggtatt agatataaat tcatatactt atataagcac 3240 tgtccacaat tttcagagtc gagtcctttc attttcaaca atctctttaa ctccactata 3300 gatcccaact tttctcacta taaaaggaac ccatttcctc tttccttcaa tcactttatc 3360 ttcttacacc aaatctatct tcaagacttc aacatactcc attctctata tacaaccttt 3420 ttaagaaaac tttgattaat cagatcaaat atttataaat taaaacacac acacactttc 3480 tcaaca atg aga ttc tct ctt tct ccc gta cgt ccg cat agt gta gta 3528 Met Arg Phe Ser Leu Ser Pro Val Arg Pro His Ser Val Val 1 5 10 gta cct tca cta cca aaa cag gac gtc gtt tct tat ata agt ggt acg 3576 Val Pro Ser Leu Pro Lys Gln Asp Val Val Ser Tyr Ile Ser Gly Thr 15 20 25 30 acg tcg aat cgt caa tgt cga tgt gta ctt aca ctt cct tct cct tca 3624 Thr Ser Asn Arg Gln Cys Arg Cys Val Leu Thr Leu Pro Ser Pro Ser 35 40 45 gtt tcc act tcc cga cca ccg gtt tta ccc aaa ccg gaa acc tgg gag 3672 Val Ser Thr Ser Arg Pro Pro Val Leu Pro Lys Pro Glu Thr Trp Glu 50 55 60 agt ttg ctg cta aac cat gat caa att cca ggc gaa ttc tca ccc ac t 3720 Ser Leu Leu Leu Asn His Asp Gln Ile Pro Gly Glu Phe Ser Pro Thr 65 70 75 ggt tcg agt atc ccg gtt aag ctt ggc cgg aga tgg atg gag tat cag 3768 Gly Ser Ser Ile Pro Val Lys Leu Gly Arg Arg Trp Met Glu Tyr Gln 80 85 90 ggg ctt caa aat tgg gac ggt ctt tta gac cca ttg gac gac aat ctc 3816 Gly Leu Gln Asn Trp Asp Gly Leu Leu Asp Pro Leu Asp Asp Asn Leu 95 100 105 110 cgg cga gag att ctc cgg tac ggt caa ttt gtc gaa tcg gct tat caa 3864 Arg Arg Glu Ile Leu Arg Tyr Gly Gln Phe Val Glu Ser Ala Tyr Gln 115 120 125 gca ttt gat ttc gat cct tcc tct cca acc tac ggg aca tgc cgg ttt 3912 Ala Phe Phe Asp Pro Ser Ser Pro Thr Tyr Gly Thr Cys Arg Phe 130 135 140 ccg agg agc acg ttg tta gag cga tcc ggt tta ccc aac tcc ggt tat 3960 Pro Arg Ser Thr Leu Leu Glu Arg Ser Gly Leu Pro Asn Ser Gly Tyr 145 150 155 cga cta acg aag aac ctt cgt gcc acg tca ggt att aac ttg cca cgt 4008 Arg Leu Thr Lys Asn Leu Arg Ala Thr Ser Gly Ile Asn Leu Pro Arg 160 165 170 tgg att gag aaa gcg cca agc tgg atg gct aca caa tc t agc tgg att 4056 Trp Ile Glu Lys Ala Pro Ser Trp Met Ala Thr Gln Ser Ser Trp Ile 175 180 185 190 ggt tac gtg gca gtt tgc cag gac aaa gaa gag atc tcg cgg ctt ggg 4104 Gly Tyr Val Ala Val Cys Gln Asp Lys Glu Glu Ile Ser Arg Leu Gly 195 200 205 cgt aga gac gtc gtc atc tcc ttc cgt gga acc gcc acg tgt ctc gag 4152 Arg Arg Asp Val Val Ile Ser Phe Arg Gly Thr Ala Thr Cys Leu Glu 210 215 220 tgg tta gag aac ctt cgc gcc acg ctg act cat ctc cct aat ggg cct 4200 Trp Leu Glu Asn Leu Arg Ala Thr Leu Thr His Leu Pro Asn Gly Pro 225 230 235 act gga gca aat cta aac ggg tct aac tct ggg ccc atg gtt gag agc 4248 Thr Gly Ala Asn Leu Asn Gly Ser Asn Ser Gly Pro Met Val Glu Ser 240 245 250 ggg ttt tta agc ttg tat act tca ggt gtt cac agt ttg aga gac atg 4296 Gly Phe Leu Ser Leu Tyr Thr Ser Gly Val His Ser Leu Arg Asp Met 255 260 265 270 gta aga gaa gag atc gca agg cta ctc caa tct tac ggc gac gag ccg 4344 Val Arg Glu Glu Ile Ala Arg Leu Leu Gln Ser Tyr Gly Asp Glu Pro 275 280 285 tta agt gta acg ata acc ggt cac agc ctc ggc gct gcg atc gcg aca 4392 Leu Ser Val Thr Ile Thr Gly His Ser Leu Gly Ala Ala Ile Ala Thr 290 295 300 cta gca gct tac gat atc aaa acg acg ttt aaa cgt gcg cct atg gtt 4440 Leu Ala Ayr Tyr Asp Ile Lys Thr Thr Phe Lys Arg Ala Pro Met Val 305 310 315 acc gta ata tct ttc gga ggt cca cgt gtc gga aac aga tgc ttt cgg 4488 Thr Val Ile Ser Phe Gly Gly Pro Arg Val Gly Asn Arg Cys Phe Arg 320 325 330 aaa ctc ctt gag aag caa ggc acg aag gtt cta aga atc gtg aac tcc 4536 Lys Leu Leu Glu Lys Gln Gly Thr Lys Val Leu Arg Ile Val Asn Ser 335 340 345 350 gac gac gtc atc acc aaa gtt cct gga gtt gtt tta gaa aac aga gag 4584 Asp Asp Val Ile Thr Lys Val Pro Gly Val Val Leu Glu Asn Arg Glu 355 360 365 caa gat aac gtt aag atg aca gcg tcg ata atg ccg agc tgg ata cag 4632 Gln Asp Asn Val Lys Met Thr Ala Ser Ile Met Pro Ser Trp Ile Gln 370 375 380 aga cgc gtg gag gag acg ccg tgg gtt tac gct gaa atc ggt aag gag 4680 Arg Arg Val Glu Glu Thr Pro Trp Val Tyr Ala Glu Ile Gly Lys Glu 385 390 395 395 ctt cgg ctg agt agc cgt gac tcg ccg cac ttg agc agc atc aat gtg 4728 Leu Arg Leu Ser Ser Arg Asp Ser Pro His Leu Ser Ser Ile Asn Val 400 405 410 gcc acg tgt cat gag ctg aaa acg tat tta cat ttg gta gac ggg ttt 4776 Ala Thr Cys His Glu Leu Lys Thr Tyr Leu His Leu Val Asp Gly Phe 415 420 425 430 gtg agc tcc acg tgt cca ttc aga gaa aca gct cgg aga gtt ctc cat 4824 Val Ser Ser Thr Cys Pro Phe Arg Glu Thr Ala Arg Arg Val Leu His 435 440 445 aga tgaagattca ttgatccgac attcgtaact aatttaattt tgtgcaaaga 4877 Arg aacactaaac cgggaagaaa atcaagaacc gcgtaacggt ttgattcggt taacaaatca 4937 atttcgtgac atatctctaa cttagcggta gaattagaaa agaaagtaaa gtagaagaca 4997 gctctaaagg gcgaaaaatg aaaaatgtat tgaagctcgt ataatctcaa attgtttata 5057 tactgtatag tgtttttaaa aaaaattgcc ggtaattatg aaaatgtggt cataaatcat 5117 aaaattttgt cgcacgagca tgtgctacta aaactcctaa aggcgtaaat tgtcttaact 5177 tggacagaaa aggaagtgaa aagacaaaaa tgtccctatc tccgtccaaa tatgagaaat 5237 gggaatgccc caatgatggt gccacgtaag caccgaccgt tcgaagaagt tgactggatc 5297 tctg tacttg gcaaaaaagc ttaaaagatt cagttgcttg caaaatctga atgcccaatg 5357 agaacacgca tcatgcgccg tccatttatt taccgtatag tatttacttt cctcgttacc 5417 aggaaaattc accatcaacg cgttattttg tgggtgtgtc atgtctgtgt tgttttaaaa 5477 ctctccataa aagttggttt tatgttaacg tactactaag aaagaccata aaataatggc 5537 caagaaatgg gatatatgat tctcgtgata atgcgttatt ctatgagtaa tataaagcaa 5597 actagtgttc agttccatgt gtattaatat aaaagtatca tgttgtataa gtaaatagaa 5657 tatttcaaaa taattataat atttctatat gtatgctaaa cataattaca tggttcattg 5717 gcgtagagaa aataacattt tatcatgttt tgtatatatc ttaatgcata acacattctc 5777 acttagaact atctattatc tatttatttt tattttataa tattgtgttt ttcatttaat 5837 ataaaaaatt cagacaatga tatatactca aaataatctt tcaaaaacac ataaaattat 5897 catcgaacag gaagggtaaa taatagaaga tcttttttgt ttgtgtgtgg gttaaatata 5957 tgacggactc taagcatatg attatgtagt cattgaaatt agatatagtt ttcaattttt 6017 catatagtcg ttccttcttt tctcaaaaag aaaccactta actgagaagt gcacgaaaac 6077 ggtcagcatc actgtttttg cggtgacttg aaagggagaa tatatcgcat gcaaagatcc 6137 aagccgtata cgtacatata caggcacgtc gtagtctcaa atatatatgc acaaaagtga 6197 atagatcgca taccgaccca tacctaaaat gctagctttg aagctataca tagctttaga 6257 aagtgaccat catcgtcatc gttacttgtt actttgttag acccacacca ttcctcgtcc 6317 aaaaatctat caaatatgga gaccgccaca tattttagat tattaagctt atattgaagg 6377 gttttatatt tctttcttgc gtacatttct ctttcgtttt ctctaatgat ttaagttaga 6437 ttagagaggt caataacgta tgcagttaac cttttccatt tcccgttatt gtggaaacct 6497 cagtttgact acatactccg accacttttt agtgatattt aacacaaaaa gaacttttga 6557 aaaactaatt tatcggtgtg actttttttg ttcgcttgtg catttttttc caacactggt 6617 ccataagttt accatgtaac atatattagt atttagagtt agtatatttc tacaaatatg 6677 tgcacagcta gctagcatta cttggaccct taaaggtgac atgtattgga tataggaaat 6737 caggacccct ttagcaaaaa aaaaaaaaag aaaaaaaaaa gaaaatcagg accatcttaa 6797 aactatttgt tcctctctat ataatggttt ataatcataa ttaagattta aagtacaaat 6857 tatagttatt aaaaaggtta gttctcacag ataataacag aaaatatttt aagttaccaa 6917 ttttagcaca taatatctaa agtttttaaa atactatgaa tttaatatca aaaatcttat 6977 ataagtattt gatgg acgct ttacgcgata ataatagaat catgatttca aattgtgatt 7037 aattttttac gtaattcggt gaagataagt aattcttgta taaatttcac taatgttaat 7097 tttaaaagtt tatggaagat atgatataat tgttcataaa acttgttata atgctattat 7157 aagatatttt tcttaaaaag acaagtaaat tactttgttc gtcgaacaca aactaactta 7217 cgcttgatca agctgtattc tacaaaagtt atacattatt aatttatcat tacaaaaatt 7277 ggaaaaaggt tactttaaca attcaaaaat atatcgaaat ccaaaaagat ttatcaactc 7337 cttttaaatt tcacgtttta cgtgaatcat gtgatataat catatgcata caaatgtcat 7397 ctgagagatt tcagccgact tttgaacaag gaccaaaaca gcctacgcca tgcggagacc 7457 acgaaaatag atattttatt ataaataaat ggattttttt ggacgtaatg aaacgagaag 7517 tggatcagaa gattaattac ataatctttt ctatttataa atttaaacta tttctttcta 7577 attcattaac aattttgata catcaggaca atggtaactt atgttactat aagacaatgg 7637 taatatctca atagaagttt ttttttgtaa aatcgcaata tatacatgaa ttaataatga 7697 catatgatgg tcatttggac ataatataaa aatataaata tttggcaaaa taaataagta 7757 aatgaagggg agaggaatgt gtgagtgtgt gtgggtgtgg atgcctttat gcctcctaca 7817 tctcaacatt gagcaaaatt gcggctgccc aacaaccacc caaaagagaa ttagtcaaaa 7877 ttattaaaat caatgcatgt cctaatctct ctcacccaac tctcaccttc atttcaactc 7937 ccatgcatct ttttggtcaa ttaatttatt aatattataa atatattttt tcaatgaatt 7997 ttgaaaagac tgtgttgcat attaaaataa tgcgttgtac tattaagagt caaattagaa 8057 aatgtacttt taactccaaa ttaatttaca acatcttaga ttatgttatt tttttttttt 8117 caagtcttca cgtacg 8133 <210> 2 <211> 447 <212> PRT <213 > Arabidopsis thaliana <400> 2 Met Arg Phe Ser Leu Ser Pro Val Arg Pro His Ser Val Val Val Pro 1 5 10 15 Ser Leu Pro Lys Gln Asp Val Val Ser Tyr Ile Ser Gly Thr Thr Ser 20 25 30 Asn Arg Gln Cys Arg Cys Val Leu Thr Leu Pro Ser Pro Ser Val Ser 35 40 45 Thr Ser Arg Pro Pro Val Leu Pro Lys Pro Glu Thr Trp Glu Ser Leu 50 55 60 Leu Leu Asn His Asp Gln Ile Pro Gly Glu Phe Ser Pro Thr Gly Ser 65 70 75 80 Ser Ile Pro Val Lys Leu Gly Arg Arg Trp Met Glu Tyr Gln Gly Leu 85 90 95 Gln Asn Trp Asp Gly Leu Leu Asp Pro Leu Asp Asp Asn Leu Arg Arg 100 105 110 Glu Ile Leu Arg Tyr Gly Gln Phe Val Glu Ser Ala Tyr Gln Ala Phe 115 120 125 Asp Phe Asp Pro Ser Ser Pro Thr Tyr Gly Thr Cys Arg Phe Pro Arg 130 135 140 Ser Thr Leu Leu Glu Arg Ser Gly Leu Pro Asn Ser Gly Tyr Arg Leu 145 150 155 160 Thr Lys Asn Leu Arg Ala Thr Ser Gly Ile Asn Leu Pro Arg Trp Ile 165 170 175 Glu Lys Ala Pro Ser Trp Met Ala Thr Gln Ser Ser Trp Ile Gly Tyr 180 185 190 Val Ala Val Cys Gln Asp Lys Glu Glu Ile Ser Arg Leu Gly Arg Arg 195 200 205 Asp Val Val Ile Ser Phe Arg Gly Thr Ala Thr Cys Leu Glu Trp Leu 210 215 220 Glu Asn Leu Arg Ala Thr Leu Thr His Leu Pro Asn Gly Pro Thr Gly 225 230 235 240 Ala Asn Leu Asn Gly Ser Asn Ser Gly Pro Met Val Glu Ser Gly Phe 245 250 255 Leu Ser Leu Tyr Thr Ser Gly Val His Ser Leu Arg Asp Met Val Arg 260 265 270 Glu Glu Ile Ala Arg Leu Leu Gln Ser Tyr Gly Asp Glu Pro Leu Ser 275 280 285 Val Thr Ile Thr Gly His Ser Leu Gly Ala Ala Ile Ala Thr Leu Ala 290 295 300 Ala Tyr Asp Ile Lys Thr Thr Phe Lys Arg Ala Pro Met Val Thr Val 305 310 315 320 Ile Ser Phe Gly Gly Pro Arg Val Gly Asn Arg Cys Phe Arg Lys Leu 325 330 335 Leu Glu Lys Gln Gly Thr Lys Val Leu Arg Ile Val Asn Ser Asp Asp 340 345 350 Val Ile Thr Lys Val Pro Gly Val Val Leu Glu Asn Arg Glu Glu Gln Asp 355 360 365 Asn Val Lys Met Thr Ala Ser Ile Met Pro Ser Trp Ile Gln Arg Arg 370 375 380 Val Glu Glu Thr Pro Trp Val Tyr Ala Glu Ile Gly Lys Glu Leu Arg 385 390 395 400 Leu Ser Ser Arg Asp Ser Pro His Leu Ser Ser Ile Asn Val Ala Thr 405 410 415 Cys His Glu Leu Lys Thr Tyr Leu His Leu Val Asp Gly Phe Val Ser 420 425 430 Ser Thr Cys Pro Phe Arg Glu Thr Ala Arg Arg Val Leu His Arg 435 440 445 <210> 3 <211> 3422 <212> DNA <213 > Arabidopsis thaliana <220> <221> promoter <222> (1) .. (3422) <400> 3 aagcttcttt attacccaat taagtaaata tcccaaacaa ttccattttg catgtaaact 60 taatgtcact attccctaaa ttaaattaca caaaattgca gtgtatgtta tgatgattgt 120 ttgatacttt attccctcct agatattatc ttaaagatca acctttgtgt tgagtaattt 180 cgttgtatag gcttgtggaa tatatacttc aattcttatc agaccataga gtcagatcat 240 ttccacgaat ccttatagaa acatttagtt atgaaataaa acacatccga aataactagc 300 tat tagatat aagaaaaaat ttaaaaatat tattgctcat cacagatttt ggaaaaatat 360 atattcatct aatcatgtta atagtcgcca tatatatacg cacattattg ttaaattgaa 420 caatctttgt aaaattatgt ttgttttgaa tattcttata aacatagaga aaattgcata 480 ttatctgttt gtaatgaaac gtatatttat tatatataga ccgatataca ataaagtagc 540 tagtaatagt attgaacaac aattgatcac caaaagaaag ttgttagctg gcttctgatg 600 gtttaacggc tcagttatga cttattcgag ctgcaccaga tactgttagc ttgctttagt 660 cgactttttt ttttttttaa caaacaaatg aaaatagtcg ttaagaagga cttcattgtt 720 agctactaac atacattcat tcatttgggt tatattatgc atgtagaaaa ctcatatgat 780 aaaatgtgcc gaatcgagcc taacaaacag gggacatggc agtaaatata gttataaatt 840 ttcttacacc ctattacaga gaaaggtgaa ttttgttttt tttgtcacag tgaaatttgt 900 ttatatattg aaatatttat acatgcataa actataaact atagttataa gtgtaattgt 960 ctctctttgc cctttttctt tatttcaaga atggtagctt aagtatataa gttttacttg 1020 taaataagtt ttggtagtat atagaagaat ccgagtagaa aactcatact aagtactata 1080 gagcatgaga aataagaaat tcataatgta gtttatcgta tgagttgact ggatgataga 1140 taccataaat atattaagt t aaaagattct actaaacgaa gaccaactgc aaagctacgt 1200 atatatttat ccactgcgta aactaaactt tttctctaca tcgatctctc aatctttggt 1260 cggttcactt tacaaatcat aaatatataa gagtcggttt agttctttac aaaaaatcaa 1320 catcgatcaa agttgatgtc atggctatca ctccattctt ctctgttggc ctcctttaaa 1380 atttacctct taattttctt ttggtatgga aagaagaaat actctttaat gttttccgta 1440 acaacgtgga caaatggtcc cgaaagaaga aatggccaat gtaaatgata ttgaaatagt 1500 cccatcggaa aaaagagtga agaaattaaa cattataaag aaccaattaa tggcttttgt 1560 ggtgtgtagt attgtgtcca caaatatatg aatggtcacg ttggtttgat atatccaaaa 1620 cgatgacatt taaatcgggg aatgtaagta aagtacgtgt cataaccaat agttctaaag 1680 tggtgcatgc aatttttgtt tattacaaaa caagaaattt gttcccaatc gattggaaca 1740 ccaaatcact ttaattgctt aagcactttg atcgtattcc taacgaagac attttccacg 1800 cgttccatgt gcatctcctc ctcagtatct atggtttatc gtgtaaatta aaactccttt 1860 cttcaagtta gttcatagtc tacataattc tttttactgc atataacata taatattctg 1920 taagatatca agaatctaaa agtgttttta ttactagtgt cccacgtggg taacatttga 1980 aatgcattca aacgatgtga taat gtgaaa tgcttaaaag tatatagagt taaaacagtc 2040 tttcagaaat cacgatggtt atcaatacaa tataaagaaa atattgcaaa acagctaaga 2100 ctctaatagg atttataaat gaaaagaggc tatatgttat taaaaagcac aagactaata 2160 tataaagagc tacgacatgt gatgtgaaat tcaaatagta agtaactcac gttgcacttc 2220 ttttattcgt cgttttgccc gaacaacaca tcactccaac ttatttaatt ggacttattc 2280 tgttacccgc gatataggct agcaagataa atttcatcgc gacatttcat atcttgatca 2340 ttctgcctta ttcaatggat tcattcaacc attctctgct catttggata tgatcattta 2400 cacttacatt ttatatttag attctaagtc gataactaat tttaagattg ttatatgttg 2460 cttttatacg tagacataaa acttgtcgtt aattgtataa aaacaatatg ctagaagcct 2520 agaagggcgt gggaatatag gaggtgtata cttcgtactt tccttgagca ttcaaattca 2580 gcaattggcg gcgaatggct aaagccgaaa gtaccaaatc cagccgatat gagccgagtc 2640 gagctggtga tagttcctca cgtgtcaaag cctttctgag ccgtattgtt tgagaactcc 2700 cacgtgtcca gtcccatcga aaacgacggt cagatattta tttcgataca cacttctttc 2760 tcttctcata tcatctcagc cgtccatttc tcttagtctc attatcatac atttacttct 2820 tctttttttt tttggtcacc aattcggtta aatccttttt tttttgtaaa tataagtcac 2880 attaaaaaag agagtaaaaa cgtgatgtca aaaacacaac taataacgta gaatccattc 2940 atgatcccaa atattgattt cacattgtct ttatggtcca tgttagttaa gtaaaagaaa 3000 gaaagagcaa acatagctta tgtgtaccac ataatcattt atatagtatt gaaactttgt 3060 caaagattgt actcattctt catagaataa aatatacaaa cccagctatt gttagctttc 3120 taatttggta catttattgc ttttacatac acgaaaacta cttgaaatcc tacatacaca 3180 aacgagtacc aatgtgtgta tttgggtatt agatataaat tcatatactt atataagcac 3240 tgtccacaat tttcagagtc gagtcctttc attttcaaca atctctttaa ctccactata 3300 gatcccaact tttctcacta taaaaggaac ccatttcctc tttccttcaa tcactttatc 3360 ttcttacacc aaatctatct tcaagacttc aacatactcc attctctata tacaaccttt 3420 tt 3422
【図1】T-DNAタギングに使用した遺伝子導入ベクター
の図。FIG. 1 is a diagram of a gene transfer vector used for T-DNA tagging.
【図2】野生型(WS)およびdad1突然変異体の花および
葯の形態を示す写真。FIG. 2 is a photograph showing the morphology of wild type (WS) and dad1 mutant flowers and anthers.
【図3】DAD1遺伝子クローニングの概要を示す図。FIG. 3 is a diagram showing an outline of DAD1 gene cloning.
【図4】相補性実験に用いた遺伝子導入ベクターの構造
を示す図。FIG. 4 is a diagram showing the structure of a gene transfer vector used in a complementation experiment.
【図5】アンチセンスDAD1遺伝子植物導入ベクターの構
造を示す図。FIG. 5 is a diagram showing the structure of an antisense DAD1 gene plant introduction vector.
【図6】アンチセンスDAD1を形質転換したシロイヌナズ
ナの花および葯の形態を示す写真。FIG. 6 is a photograph showing morphology of flowers and anthers of Arabidopsis thaliana transformed with antisense DAD1.
【図7】プロモーター−GUS遺伝子導入ベクターの構造
を示す図。FIG. 7 shows the structure of a promoter-GUS gene transfer vector.
【図8】DAD1遺伝子をプローブにしたサザンハイブリダ
イゼーションの結果を示す図。FIG. 8 is a diagram showing the results of Southern hybridization using the DAD1 gene as a probe.
フロントページの続き (72)発明者 小田 明子 愛知県岡崎市明大寺町字西郷中38番地 岡崎国立共同研究機構基礎生物学研究所 (56)参考文献 特開 平7−59573(JP,A) 特表 平8−507691(JP,A) Plant J.,10(4),679− 689(1996) Sex.Plant Repro d.,11(6),297−322(1999) (58)調査した分野(Int.Cl.7,DB名) C12N 15/00 - 15/90 GenBank/EMBL/DDBJ/G eneSeq SwissProt/PIR/GeneS eq BIOSIS(DIALOG) WPI(DIALOG)Continuation of the front page (72) Inventor Akiko Oda 38, Saigo-naka, Meidaiji-cho, Okazaki-shi, Aichi Okazaki National Collaborative Research Organization (56) Reference JP-A-7-59573 (JP, A) Table 8-507691 (JP, A) Plant J. , 10 (4), 679-689 (1996) Sex. Plant Repro d. , 11 (6), 297-322 (1999) (58) Fields investigated (Int. Cl. 7 , DB name) C12N 15/00-15/90 GenBank / EMBL / DDBJ / GeneSeq SwissProt / PIR / GeneSeq BIOSIS (DIALOG) WPI (DIALOG)
Claims (6)
数個の塩基が欠失、置換若しくは付加された塩基配列に
より表され、プロモーター活性を有するDNAであって、
(a)のDNAに、部位特異的変異誘発法によって変異を生じ
させることにより得ることのできるDNA (1 ) a DNA represented by the following (a) or (b): (a) a DNA represented by the nucleotide sequence of SEQ ID NO: 3 (b) a nucleotide sequence in which one or more bases have been deleted, substituted or added in the nucleotide sequence of SEQ ID NO: 3
And DNA having promoter activity,
Mutation is generated in the DNA of (a) by site-directed mutagenesis
DNA that can be obtained by
ンパク質をコードするDNA (b)配列番号2に記載のアミノ酸配列において1若しく
は複数個のアミノ酸が欠失、置換若しくは付加されたア
ミノ酸配列により表され、葯の裂開を制御する機能を有
するタンパク質をコードするDNAであって、(a)のDNA
に、部位特異的変異誘発法によって変異を生じさせるこ
とにより得ることのできるDNA 2. The DNA shown in (a) or (b) below. (a) a DNA encoding a protein represented by the amino acid sequence of SEQ ID NO: 2 (b) an amino acid sequence in which one or more amino acids have been deleted, substituted or added in the amino acid sequence of SEQ ID NO: 2 A DNA encoding a protein having a function of controlling anther dehiscence, wherein the DNA of (a)
Should be mutated by site-directed mutagenesis.
DNA obtained by
により表されるDNA。3. A DNA represented by a nucleotide sequence complementary to the DNA according to claim 2.
いることを特徴とする雄性不稔植物。4. A male sterile plant, wherein the expression of the DNA according to claim 2 is suppressed.
とを特徴とする雄性不稔植物の作出方法。5. A method for producing a male sterile plant, which comprises suppressing the expression of the DNA according to claim 2.
ン酸、リノレン酸、又はそれらの誘導体で処理すること
を特徴とする稔性回復方法。6. A method for restoring fertility, comprising treating the male sterile plant according to claim 4 with jasmonic acid, linolenic acid, or a derivative thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11115002A JP3138452B2 (en) | 1999-04-22 | 1999-04-22 | Genes involved in anther dehiscence |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11115002A JP3138452B2 (en) | 1999-04-22 | 1999-04-22 | Genes involved in anther dehiscence |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000300273A JP2000300273A (en) | 2000-10-31 |
| JP3138452B2 true JP3138452B2 (en) | 2001-02-26 |
Family
ID=14651873
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11115002A Expired - Fee Related JP3138452B2 (en) | 1999-04-22 | 1999-04-22 | Genes involved in anther dehiscence |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3138452B2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100537955B1 (en) * | 2003-10-29 | 2005-12-20 | 학교법인고려중앙학원 | A solely pollen-specific promoter |
| KR100741255B1 (en) | 2006-07-14 | 2007-07-19 | 고려대학교 산학협력단 | Plant Hormone Jasmonic Acid and Ethylene Biosynthesis Associated with Inhibition of Ethylene Biosynthesis |
| CN102433310B (en) * | 2011-12-02 | 2013-04-03 | 北京市农林科学院 | Relevant protein TaAOC for regulating and controlling cracking of plant anther as well as gene and application thereof |
| NL2036191B1 (en) * | 2023-11-06 | 2025-05-27 | Rijk Zwaan Zaadteelt En Zaadhandel Bv | Reversible male sterility in rocket plants |
-
1999
- 1999-04-22 JP JP11115002A patent/JP3138452B2/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| Plant J.,10(4),679−689(1996) |
| Sex.Plant Reprod.,11(6),297−322(1999) |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000300273A (en) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3156792B2 (en) | DNA sequence showing cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria comprising the sequence, and methods for producing plants and hybrids | |
| JPH06501380A (en) | Method for producing hybrid seeds by dual latent cytotoxicity method | |
| JP2002504335A (en) | Pollen-specific promoter | |
| JP2002354954A (en) | Reversible nuclear genetic system for male sterility in transgenic plants | |
| US11479784B2 (en) | Modulation of seed vigor | |
| JPH0646697A (en) | Control of microsporulation using an externally inducible promoter sequence | |
| HU220185B (en) | Transgenic plants, methods for producing them, and the intervening genetic tools | |
| US5585543A (en) | Alteration of plant self-compatibility using genetic manipulation of the S-genes | |
| JPH11500627A (en) | Genetic transformation using PARP inhibitors | |
| JP3138452B2 (en) | Genes involved in anther dehiscence | |
| WO2010115297A1 (en) | Restoring recessive genic male sterile gene bncyp704b1 of brassica napus and use thereof | |
| JP7701739B2 (en) | Method for producing temperature-sensitive male-sterile plants | |
| EP1645630A1 (en) | Method of improving fertility of hybrid plant comprising locating fertility restoration genes on plural loci | |
| JP6502320B2 (en) | Hybrid Brassica plant and method for producing the same | |
| WO2001037643A1 (en) | Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes | |
| JP3952246B2 (en) | A method for reducing pollen fertility using a pollen-specific zinc finger transcription factor gene | |
| AU5977098A (en) | Production of self-compatible (brassica) hybrids using a self-incompatible pollination control system | |
| JP3619704B2 (en) | Method for producing plant exhibiting specific S-locus type | |
| CN106754964A (en) | The clone of cabbage type rape nap cytoplasmic male sterility Restore genes Rfn and its application | |
| CN120835897A (en) | Nuclear male sterility in watermelon | |
| JP2003092937A (en) | A method for reducing pollen fertility using a gene for a pollen-specific zinc finger transcription factor | |
| WO2026034537A1 (en) | Nucleic acid for controlling number of florets per spikelet | |
| WO2024206563A2 (en) | Acetyl-coa carboxylase inhibitor resistant sorghum | |
| JP2007202561A (en) | A method for reducing pollen fertility using a pollen-specific zinc finger transcription factor gene | |
| HU221518B (en) | Nucleotide sequences mediating male fertility and method of using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |